Document:

EX-4.2

 Exhibit 4.2 
  

 
  

FORM OF REGISTRATION RIGHTS AGREEMENT 

BY AND AMONG 
 EVOLENT
HEALTH, INC. 
 AND 

CERTAIN STOCKHOLDERS 

DATED AS OF [            ], 2015 

 
  

 

 TABLE OF CONTENTS 
  

							
	 	 	 	  	Page	 
	ARTICLE I	  
	
	Effectiveness	  
	 Section 1.1.
	 	 Effectiveness
	  	 	2	  
	
	ARTICLE II	  
	
	Definitions	  
			
	 Section 2.1.
	 	 Definitions
	  	 	2	  
	
	ARTICLE III	  
	
	Registration Rights	  
			
	 Section 3.1.
	 	 Demand Registration
	  	 	8	  
			
	 Section 3.2.
	 	 Shelf Registration
	  	 	11	  
			
	 Section 3.3.
	 	 Piggyback Registration
	  	 	15	  
			
	 Section 3.4.
	 	 Lock-Up Agreements
	  	 	17	  
			
	 Section 3.5.
	 	 Registration Procedures
	  	 	17	  
			
	 Section 3.6.
	 	 Underwritten Offerings
	  	 	23	  
			
	 Section 3.7.
	 	 No Inconsistent Agreements; Additional Rights
	  	 	25	  
			
	 Section 3.8.
	 	 Registration Expenses
	  	 	25	  
			
	 Section 3.9.
	 	 Indemnification
	  	 	25	  
			
	 Section 3.10.
	 	 Rules 144 and 144A and Regulation S
	  	 	29	  
			
	 Section 3.11.
	 	 Existing Registration Statements
	  	 	29	  
	
	ARTICLE IV	  
	
	Miscellaneous	  
			
	 Section 4.1.
	 	 Authority: Effect
	  	 	30	  
			
	 Section 4.2.
	 	 Notices
	  	 	30	  
			
	 Section 4.3.
	 	 Termination and Effect of Termination
	  	 	32	  
			
	 Section 4.4.
	 	 Permitted Transferees
	  	 	32	  
			
	 Section 4.5.
	 	 Remedies
	  	 	33	  
			
	 Section 4.6.
	 	 Amendments
	  	 	33	  
			
	 Section 4.7.
	 	 Governing Law
	  	 	33	  

							
	 Section 4.8.
		 Consent to Jurisdiction
		 	33	  
			
	 Section 4.9.
		 WAIVER OF JURY TRIAL
		 	34	  
			
	 Section 4.10.
		 Merger; Binding Effect, Etc.
		 	34	  
			
	 Section 4.11.
		 Counterparts
		 	34	  
			
	 Section 4.12.
		 Severability
		 	35	  
			
	 Section 4.13.
		 No Recourse
		 	35	  

  
 ii 

 This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in
accordance with the terms hereof, the “Agreement”), dated as of [            ], 2015, is made by and among: 

i. Evolent Health, Inc., a Delaware corporation (the “Company”); 

ii. TPG Growth II BDH, L.P., a Delaware limited partnership, and TPG Eagle Holdings, L.P., a Delaware limited partnership (together with their
Permitted Transferees that become party hereto, the “TPG Investor”); 
 iii. UPMC, a Pennsylvania nonprofit corporation
(together with its Permitted Transferees that become party hereto, the “UPMC Investor”); 
 iv. The Advisory Board Company,
a Delaware corporation (together with its Permitted Transferees that become party hereto, “The Advisory Board Investor” and, together with the TPG Investor and the UPMC Investor, the “Principal Investors”); 

v. Ptolemy Capital, LLC (the “Ptolemy Investor” and a Holder (as defined herein) for the purposes of this Agreement); and

 vi. such other Persons, if any, that from time to time become party hereto as holders of Registrable Securities pursuant to
Section 4.4 in their capacity as Permitted Transferees. 
 RECITALS 

WHEREAS, on January 6, 2014, Evolent Health Holdings, Inc., a Delaware corporation, Evolent Health LLC, a Delaware limited liability
company (“Evolent Health LLC”), the TPG Investor, the UPMC Investor, The Advisory Board Investor and certain other Persons entered into an Amended and Restated Master Investors’ Rights Agreement (the “Prior
Agreement”), which, among other things, provided the Principal Investors with registration rights with respect to the common stock of Evolent Health Holdings, Inc.; 

WHEREAS, the Company has effected a series of reorganization transactions (the “Reorganization Transactions”) in connection
with an initial public offering (the “IPO”) of shares of the Company’s Class A common stock, par value $0.01 per share (the “Class A Common Stock”); 

WHEREAS, after giving effect to the Reorganization Transactions, the TPG Investor and The Advisory Board Investor own Class B limited
liability company interests in Evolent Health LLC (“Class B common units”), together with shares of the Company’s Class B common stock, par value $0.01 per share (the “Class B Common Stock” and, together
with the Class A Common Stock, the “Common Stock”), which, subject to certain restrictions, are exchangeable from time to time at the option of the holder thereof for shares of the Company’s Class A Common Stock,
pursuant to an Exchange Agreement dated [            ], 2015 (the “Exchange Agreement”); 

 WHEREAS, after giving effect to the Reorganization Transactions, The Advisory Board Investor and
the UPMC Investor own shares of Class A Common Stock. 
 WHEREAS, on the date hereof, the Company has consummated the IPO pursuant to
an Underwriting Agreement dated [            ], 2015 (the “Underwriting Agreement”); 

WHEREAS, the Prior Agreement is being terminated by the parties thereto effective as of the closing of the IPO (the “Closing”); and

 WHEREAS, the parties believe that it is in the best interests of the Company and the other parties hereto to set forth their agreements
regarding registration rights and certain other matters following the IPO. 
 NOW, THEREFORE, in consideration of the foregoing and the
mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 

ARTICLE I 
 Effectiveness

 Section 1.1. Effectiveness. This Agreement shall become effective upon the Closing. 

ARTICLE II 
 Definitions

 Section 2.1. Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“Adverse Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the Board
of Directors of the Company, after consultation with outside counsel to the Company: (i) would be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement, from and after its
effective date, does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) would not be required to be made at such
time but for the filing, effectiveness or continued use of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly. 

“Advisory Board Investor” shall have the meaning set forth in the Preamble. 

  
 2 

 “Affiliate” means, with respect to any specified Person, any Person that
directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person; provided that the Company and each of its subsidiaries shall be deemed not to be Affiliates of
the TPG Investor, the UPMC Investor or The Advisory Board Investor. As used in this definition, the term “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of a Person, whether through ownership of voting securities, by contract or otherwise. For purposes of this Agreement, each of the TPG Investor, the UPMC Investor and The Advisory Board Investor shall not be deemed to be affiliates of each other
solely as a result of entering into this Agreement. 
 “Agreement” shall have the meaning set forth in the Preamble. 

“Block Trade Offering” means any bought deal or block sale to a financial institution conducted as an underwritten Public
Offering. 
 “Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or
authorized by law to be closed in the City of New York. 
 “Class A Common Stock” shall have the meaning set forth in the
Recitals. 
 “Class B Common Stock” shall have the meaning set forth in the Recitals. 

“Class B common unit” shall have the meaning set forth in the Recitals. 

“Closing” shall have the meaning set forth in the Recitals. 

“Common Stock” shall have the meaning set forth in the Recitals. 

“Demand Notice” shall have the meaning set forth in Section 3.1.3. 

“Demand Registration” shall have the meaning set forth in Section 3.1.1(a). 

“Demand Registration Request” shall have the meaning set forth in Section 3.1.1(a). 

“Demand Registration Statement” shall have the meaning set forth in Section 3.1.1(c). 

“Demand Suspension” shall have the meaning set forth in Section 3.1.6. 

“Demanding Holder” means any Principal Investor that exercises a right to request a Demand Registration pursuant to
Section 3.1. 
 “Effective Date” means the date of the Closing. 

  
 3 

 “Exchange” means the exchange of shares of Class B Common Stock (together with
Class B common units) for shares of Class A Common Stock pursuant to the Exchange Agreement. 
 “Exchange
Agreement” shall have the meaning set forth in the Recitals. 
 “Exchange Act” means the Securities Exchange Act
of 1934, as amended, and any successor thereto, and any rules and regulations promulgated thereunder, all as the same shall be in effect from time to time. 

“Excluded Registration” means (i) a registration relating to the sale of securities to employees of the Company or a
subsidiary pursuant to a stock option, stock purchase, or similar plan on Form S-8 or its successor approved by the Board of Directors of the Company or (ii) a registration statement on Form S-4 or its successor. 

“FINRA” means the Financial Industry Regulatory Authority. 

“Holders” means holders of Registrable Securities under this Agreement. 

“IPO” shall have the meaning set forth in the Recitals. 

“Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act,
relating to an offer of the Registrable Securities. 
 “Issuer Shares” means the shares of Common Stock or other equity
securities of the Company, and any securities into which such shares of Common Stock or other equity securities shall have been changed or any securities resulting from any reclassification or recapitalization of such shares of Common Stock or other
equity securities. 
 “Loss” shall have the meaning set forth in Section 3.9.1. 

“Participation Conditions” shall have the meaning set forth in Section 3.2.5(b). 

“Permitted Transferee” means with respect to any Holder, any Affiliate of such Holder. 

“Person” means any individual, partnership, corporation, company, association, trust, joint venture, limited liability
company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 

“Piggyback Notice” shall have the meaning set forth in Section 3.3.1. 

“Piggyback Registration” shall have the meaning set forth in Section 3.3.1. 

  
 4 

 “Potential Takedown Participant” shall have the meaning set forth in
Section 3.2.5(b). 
 “Principal Investor Minimum” means, with respect to a Principal Investor, at least 20% of the
shares of Common Stock held by such Principal Investor as of the closing of the transactions contemplated by the Underwriting Agreement (as adjusted for any stock dividend or distribution, stock split, reverse stock split, recapitalization,
reclassification, reorganization, stock exchange, subdivision, combination thereof or similar transaction). 
 “Principal
Investors” or “Principal Investor” shall have the meaning set forth in the Preamble. 
 “Prior
Agreement” shall have the meaning set forth in the Recitals. 
 “Pro Rata Portion” means, with respect to each
Holder requesting that its shares be registered pursuant to a Demand Registration or sold in a Public Offering, a number of such shares equal to the aggregate number of Registrable Securities requested to be registered in such Demand Registration or
sold in such Public Offering (excluding any shares to be registered or sold for the account of the Company) multiplied by a fraction, the numerator of which is the aggregate number of shares of Common Stock held by such Holder immediately prior to
the IPO, and the denominator of which is the aggregate number of shares of Common Stock held by all Holders immediately prior to the IPO. 

“Prospectus” means (i) the prospectus included in any Registration Statement, all amendments and supplements to such
prospectus, including post-effective amendments, and all other material incorporated by reference in such prospectus, and (ii) any Issuer Free Writing Prospectus. 

“Ptolemy Investor” shall have the meaning set forth in the Preamble. 

“Public Offering” means the offer and sale of Registrable Securities for cash pursuant to an effective Registration Statement
under the Securities Act (other than a Registration Statement on Form S-4 or Form S-8 or any successor form). 
 “Registrable
Securities” means (i) all shares of Class A Common Stock held by the Principal Investors as of the Closing, (ii) all shares of Class A Common Stock issuable upon exercise, conversion or exchange of any option, warrant or
convertible security (including shares of Class A Common Stock issuable upon Exchange) and (iii) all shares of Class A Common Stock directly or indirectly issued or issuable with respect to the securities referred to in clause
(i) or (ii) above by way of unit or stock dividend or unit or stock split, or in connection with a combination of units or shares, recapitalization, merger, consolidation or other reorganization. As to any particular Registrable
Securities, such securities shall cease to be Registrable Securities when (w) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed
of in accordance with such Registration Statement, (x) such securities shall have been 

  
 5 

 
Transferred to the public pursuant to Rule 144 and the restrictive legend and any stop transfer restrictions have been removed, (y) such holder is able to immediately distribute such
securities publicly without any restrictions on transfer (including without application of paragraphs (c), (d), (e), (f) and (h) of Rule 144) or (z) such securities shall have ceased to be outstanding. 

“Registration” means registration under the Securities Act of the offer and sale to the public of any Issuer Shares under a
Registration Statement. The terms “register”, “registered” and “registering” shall have correlative meanings. 

“Registration Expenses” shall have the meaning set forth in Section 3.8. 

“Registration Statement” means any registration statement of the Company filed with, or to be filed with, the SEC under the
Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement
other than a registration statement (and related Prospectus) filed on Form S-4 or Form S-8 or any successor form thereto. 

“Representatives” means, with respect to any Person, any of such Person’s officers, directors, employees, agents,
attorneys, accountants, actuaries, consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person. 

“Requisite Investor Approval” means the approval of (a) each of the Principal Investors for so long as each Principal
Investor and its Affiliates beneficially own in the aggregate the Principal Investor Minimum and (b) to the extent only one Principal Investor and its Affiliates beneficially own in the aggregate the Principal Investor Minimum, such Principal
Investor; provided that, for purposes of this definition, a Principal Investor shall be deemed to have approved an action to the extent that such Principal Investor or its Affiliates holding a majority of the Issuer Shares held by such
Principal Investor and its Affiliates in the aggregate vote in favor of, or provide their written consent to, such action. 

“Reorganization Transactions” shall have the meaning set forth in the Recitals. 

“Rule 144” means Rule 144 under the Securities Act (or any successor Rule). 

“SEC” means the Securities and Exchange Commission or any successor agency having jurisdiction under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations
promulgated thereunder, all as the same shall be in effect from time to time. 

  
 6 

 “Shelf Period” shall have the meaning set forth in Section 3.2.3. 

“Shelf Registration” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Registration Notice” shall have the meaning set forth in Section 3.2.2. 

“Shelf Registration Request” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Registration Statement” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Suspension” shall have the meaning set forth in Section 3.2.4. 

“Shelf Takedown Notice” shall have the meaning set forth in Section 3.2.5(b). 

“Shelf Takedown Request” shall have the meaning set forth in Section 3.2.5(a). 

“TPG Investor” shall have the meaning set forth in the Preamble. 

“Transfer” means, with respect to any Registrable Security, any interest therein, or any other securities or equity
interests, a direct or indirect transfer, sale, exchange, assignment or other disposition thereof, including the grant of an option or other right, whether directly or indirectly, whether voluntarily, involuntarily, by operation of law, pursuant to
judicial process or otherwise. “Transferred” shall have a correlative meaning. 
 “Underwritten Public
Offering” means an underwritten Public Offering, including any Block Trade Offering. 
 “Underwritten Shelf
Takedown” means an Underwritten Public Offering pursuant to an effective Shelf Registration Statement. 
 “Underwriting
Agreement” shall have the meaning set forth in the Recitals. 
 “UPMC Investor” shall have the meaning set forth
in the Preamble. 
 “WKSI” means any Securities Act registrant that is a well-known seasoned issuer as defined in Rule 405
under the Securities Act at the most recent eligibility determination date specified in paragraph (2) of that definition. 

Section 2.2. Other Interpretive Provisions. (a) The meanings of defined terms are equally applicable to the singular and
plural forms of the defined terms. 

  
 7 

 (b) The words “hereof”, “herein”, “hereunder” and similar words
refer to this Agreement as a whole and not to any particular provision of this Agreement; and any subsection and Section references are to this Agreement unless otherwise specified. 

(c) The term “including” is not limiting and means “including without limitation.” 

(d) The captions and headings of this Agreement are for convenience of reference only and shall not affect the interpretation of this
Agreement. 
 (e) Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter
forms. 
 ARTICLE III 

Registration Rights 
 The
Company will perform and comply, and cause each of its subsidiaries to perform and comply, with such of the following provisions as are applicable to it. Each Holder will perform and comply with such of the following provisions as are applicable to
such Holder. 
 Section 3.1. Demand Registration. 

Section 3.1.1. Request for Demand Registration. 

(a) Following the Effective Date, each of the Principal Investors shall have the right to make a written request from time to
time (a “Demand Registration Request”) to the Company for Registration of all or part of the Registrable Securities held by such Principal Investor. Any such Registration pursuant to a Demand Registration Request shall hereinafter
be referred to as a “Demand Registration.” Subject to Section 3.2.8, each of the Principal Investors shall be limited to no more than two Demand Registration Requests on Form S-1 or
any similar long-form registration statement (provided that delivery of a written notice pursuant to Section 3.1.3 shall not constitute a Demand Registration Request), and each such demand shall be required to be in respect of at least
$50 million in anticipated aggregate net proceeds from all shares sold pursuant to such registration (including after giving effect to net proceeds expected to be received by any Holder that participates in such offering after delivering
written notice pursuant to Section 3.1.3 or otherwise); provided, that a Demand Registration shall not be counted for purposes of the number of Demand Registration Requests made by the Demanding Holder that had submitted such Demand
Registration Request unless and until the Demand Registration has become effective and the Demanding Holders are able to register and sell at least 90% of the Registrable Securities requested to be included in such registration. 

  
 8 

 (b) Each Demand Registration Request shall specify (x) the aggregate amount
of Registrable Securities to be registered, and (y) the intended method or methods of disposition thereof. 
 (c) Upon
receipt of the Demand Registration Request, the Company shall as promptly as reasonably practicable file a Registration Statement (a “Demand Registration Statement”), as specified in the Demand Registration Request for such Demand
Registration, relating to such Demand Registration. The Company shall use its reasonable best efforts to cause such Demand Registration Statement to be declared effective under the Securities Act within 60 days after receipt of the Demand
Registration Request; provided that in the event that the SEC notifies the Company that it will not review a Demand Registration Statement, the Company shall cause such Demand Registration Statement to become effective no later than five
Business Days after receiving such notification. 
 Section 3.1.2. Limitation on Demand Registrations. The
Company shall not be obligated to take any action to effect any Demand Registration if a Demand Registration was declared effective or an Underwritten Shelf Takedown was consummated within the preceding 60 days (unless otherwise consented to by
the Board of Directors of the Company); provided, however, that if a prior Underwritten Shelf Takedown was executed as a Block Trade Offering, no such limitation shall apply. 

Section 3.1.3. Demand Notice. Promptly upon receipt of a Demand Registration Request pursuant to Section 3.1.1
(but in no event more than three Business Days thereafter), the Company shall deliver a written notice (a “Demand Notice”) of any such Demand Registration Request to all other Holders and the Demand Notice shall offer each such
Holder the opportunity to include in the Demand Registration that number of Registrable Securities as each such Holder may request in writing. Subject to Section 3.1.7, the Company shall include in the Demand Registration all such Registrable
Securities with respect to which the Company has received written requests for inclusion therein within three Business Days after the date that the Demand Notice was delivered. 

Section 3.1.4. Demand Withdrawal. A Demanding Holder and any other Holder that has requested its Registrable
Securities be included in a Demand Registration pursuant to Section 3.1.3 may withdraw all or any portion of its Registrable Securities included in a Demand Registration from such Demand Registration at any time prior to the execution of the
underwriting agreement related to such Demand Registration. Upon receipt of a notice to such effect from a Demanding Holder (or if there is more than one Demanding Holder, from all such Demanding Holders) with respect to all of the Registrable
Securities included by such Demanding Holder(s) in such Demand Registration, the Company shall cease all efforts to secure effectiveness of the applicable Demand Registration Statement; provided that, for the avoidance of doubt, in the event
of a 

  
 9 

 
request for a Demand Registration by more than one Holder, the Company shall continue all efforts to secure effectiveness of the applicable Demand Registration Statement with respect to the
Registrable Securities requested to be included by each of the Holders that has not withdrawn its Registrable Securities. Notwithstanding any withdrawal of Registrable Securities from a Demand Registration pursuant to this Section 3.1.4, the
Demand Registration with respect to which the withdrawal was made shall be counted for purposes of the number of Demand Registration Requests made by the Demanding Holder that had submitted the Demand Registration Request pursuant to
Section 3.1.1(a) unless (a) the Demanding Holders reimburse the Company for all expenses incurred in connection with the Demand Registration with respect to which the withdrawal was made, (b) the withdrawal is made as a result of an
event that has had a material adverse effect on the business, assets, condition (financial or otherwise) or results of operations of the Company or (c) the withdrawal is made in response to a Demand Suspension pursuant to Section 3.1.6.

 Section 3.1.5. Effective Registration. The Company shall use reasonable best efforts to cause the Demand
Registration Statement to become effective and remain effective for not less than 180 days plus the duration of any suspension period (or such shorter period as will terminate when all Registrable Securities covered by such Demand Registration
Statement have been sold or withdrawn), or, if such Demand Registration Statement relates to an Underwritten Public Offering, such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus is required by law to be
delivered in connection with sales of Registrable Securities by an underwriter or dealer. 
 Section 3.1.6. Delay in
Filing; Suspension of Registration. If the filing, initial effectiveness or continued use of a Demand Registration Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice
of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, the Demand Registration Statement (a “Demand Suspension”); provided, however, that the Company shall not be permitted to
exercise a Demand Suspension (i) more than once during any 12-month period or (ii) for a period exceeding 60 days on any one occasion. In the case of a Demand Suspension, the Holders agree to suspend use of the applicable Prospectus
in connection with any sale or purchase, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders in writing upon (a) the Company’s decision to
file or seek effectiveness of such Demand Registration Statement following such Demand Suspension and (b) the effectiveness of such Demand Registration Statement. Notwithstanding the provisions of this Section 3.1.6, the Company may not
postpone the filing or effectiveness of, or suspend use of, a Demand Registration Statement past the date upon which the applicable Adverse Disclosure is disclosed to the public or ceases to be material. During a Demand Suspension, the Company shall
be prohibited from filing a registration statement for its own account or for the account of any other Holder or holder of its securities and, upon termination of any Demand Suspension, the Company shall

  
 10 

 
promptly amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the Prospectus as so
amended or supplemented as the Holders may reasonably request. 
 Section 3.1.7. Priority of Securities Registered
Pursuant to Demand Registrations. If the managing underwriter or underwriters of a proposed Underwritten Public Offering of the Registrable Securities included in a Demand Registration, advise the Company in writing that, in its or their
opinion, the number of securities requested to be included in such Demand Registration exceeds the number that can be sold in such offering without being likely to have an adverse effect on the price, timing or distribution of the securities offered
or the market for the securities offered, then the securities to be included in such Registration shall be in the case of any Demand Registration (x) first, for each Holder that has requested to participate in such Demand Registration an amount
equal to the lesser of (i) the number of such Registrable Securities requested to be registered or sold by such Holder, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion, and (y) second, and only if all the
securities referred to in clause (x) have been included, the number of other securities that, in the opinion of such managing underwriter or underwriters can be sold without having such adverse effect. 

Section 3.1.8. Resale Rights. In the event that a Principal Investor elects to request a Registration pursuant to
this Section 3.1 in connection with a distribution of Registrable Securities to its partners, members or stockholders, the Registration shall provide for resale by such partners, members or stockholders, if requested by such Principal Investor.

 Section 3.2. Shelf Registration. 

Section 3.2.1. Request for Shelf Registration. 

(a) Upon the written request of any Principal Investor from time to time following the date on which the Company becomes
eligible to use Form S-3 or any similar short-form registration statement (a “Shelf Registration Request”), the Company shall promptly file with the SEC a shelf Registration Statement pursuant to Rule 415 under the Securities Act
(“Shelf Registration Statement”) relating to the offer and sale of Registrable Securities by any Holders thereof from time to time in accordance with the methods of distribution elected by such Holders and set forth in the Shelf
Registration Statement and the Company shall use its reasonable best efforts to cause such Shelf Registration Statement to become effective under the Securities Act as promptly as practicable, and in any event within 60 days following receipt of
such Shelf Registration Request; provided that in the event that the SEC notifies the Company that it will not review a Shelf Registration Statement, the Company shall cause such Shelf Registration Statement to become effective no later than
five 

  
 11 

 
Business Days after receiving such notification. Any such Registration pursuant to a Shelf Registration Request shall hereinafter be referred to as a “Shelf Registration.” 

(b) If on the date of the Shelf Registration Request: (i) the Company is a WKSI, then the Shelf Registration Request may
request Registration of an unspecified amount of Registrable Securities; and (ii) the Company is not a WKSI, then the Shelf Registration Request shall specify the aggregate amount of Registrable Securities to be registered. 

Section 3.2.2. Shelf Registration Notice. Promptly upon receipt of a Shelf Registration Request (but in no event
more than three Business Days thereafter), the Company shall deliver a written notice (a “Shelf Registration Notice”) of any such request to all other Holders, which notice shall specify, if applicable, the amount of Registrable
Securities to be registered, and the Shelf Registration Notice shall offer each such Holder the opportunity to include in the Shelf Registration that number of Registrable Securities as each such Holder may request in writing. Subject to
Section 3.2.6, the Company shall include in such Shelf Registration all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three Business Days after the date that the Shelf
Registration Notice has been delivered. 
 Section 3.2.3. Continued Effectiveness. The Company shall use its
reasonable best efforts to keep such Shelf Registration Statement continuously effective under the Securities Act in order to permit the Prospectus forming part of the Shelf Registration Statement to be usable by Holders until the earlier of:
(i) the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but in no event prior to the applicable period referred to in
Section 4(a)(3) of the Securities Act and Rule 174 thereunder); and (ii) the date as of which no Holder holds Registrable Securities (such period of effectiveness, the “Shelf Period”). Subject to Section 3.2.4, the
Company shall be deemed not to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily takes any action or omits to take any action that would result in Holders of
the Registrable Securities covered thereby not being able to offer and sell any Registrable Securities pursuant to such Shelf Registration Statement during the Shelf Period, unless such action or omission is required by applicable law. 

Section 3.2.4. Suspension of Registration. If the continued use of such Shelf Registration Statement at any time
would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, suspend use of the Shelf Registration Statement (a “Shelf Suspension”); provided,
however, that the Company shall not be permitted to exercise a Shelf Suspension (i) more than one time during any 12-month period, or (ii) for a period exceeding 60 days on any one occasion. In the case of a Shelf Suspension, the
Holders agree to suspend use of the applicable Prospectus 

  
 12 

 
and in connection with any sale or purchase of, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the
Holders in writing upon the termination of any Shelf Suspension, and upon such termination, promptly amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of
copies of the Prospectus as so amended or supplemented as the Holders may reasonably request. Notwithstanding the provisions of this Section 3.2.4, the Company may not postpone the filing or effectiveness of, or suspend use of, a Shelf
Registration Statement past the date upon which the applicable Adverse Disclosure is disclosed to the public or ceases to be material. During a Shelf Suspension, the Company shall be prohibited from filing a registration statement for its own
account or for the account of any other Holder or holder of its securities. 
 Section 3.2.5. Shelf Takedown.

 (a) At any time during which the Company has an effective Shelf Registration Statement with respect to a Principal
Investor’s Registrable Securities, by notice to the Company specifying the intended method or methods of disposition thereof, such Principal Investor may make a written request (a “Shelf Takedown Request”) to the Company to
effect a Public Offering, including an Underwritten Shelf Takedown, of all or a portion of such Holder’s Registrable Securities that are covered by such Shelf Registration Statement, and as soon as practicable the Company shall amend or
supplement the Shelf Registration Statement for such purpose; provided that any Underwritten Shelf Takedown Request shall be required to be in respect of at least $25 million in anticipated net proceeds in the aggregate (including after
giving effect to net proceeds expected to be received by any Holder that participates in such offering after delivering a written notice pursuant to Section 3.2.5(b)), unless a lesser amount is then held by the Principal Investors requesting to
participate in such offering. 
 (b) Promptly upon receipt of a Shelf Takedown Request (but in no event more than three
Business Days thereafter) for any Underwritten Shelf Takedown, the Company shall deliver a notice (a “Shelf Takedown Notice”) to each other Holder with Registrable Securities covered by the applicable Registration Statement (each a
“Potential Takedown Participant”). The Shelf Takedown Notice shall offer each such Potential Takedown Participant the opportunity to include in any Underwritten Shelf Takedown that number of Registrable Securities as each such
Potential Takedown Participant may request in writing. Subject to Section 3.2.6, the Company shall include in the Underwritten Shelf Takedown all such Registrable Securities with respect to which the Company has received written requests for
inclusion therein within three Business Days after the date that the Shelf Takedown Notice has been delivered. Any Potential Takedown Participant’s request to participate in 

  
 13 

 
an Underwritten Shelf Takedown in connection with a proposed Block Trade Offering shall be binding on the Potential Takedown Participant; provided that each such Potential Takedown
Participant that elects to participate may condition its participation on such Underwritten Shelf Takedown being completed within 10 Business Days of its acceptance at a price per share (after giving effect to any underwriters’ discounts or
commissions) to such Potential Takedown Participant of not less than 90% (or such lesser percentage specified by such Potential Takedown Participant in writing) of the closing price for the shares on their principal trading market on the Business
Day immediately prior to such Potential Takedown Participant’s election to participate (the “Participation Conditions”). Notwithstanding the delivery of any Shelf Takedown Notice, but subject to the Participation Conditions in
any Block Trade Offering, all determinations as to whether to complete any Underwritten Shelf Takedown and as to the timing, manner, price and other terms of any Underwritten Shelf Takedown contemplated by this Section 3.2.5 shall be determined
by the initiating Principal Investor(s); provided that if such Underwritten Shelf Takedown is to be completed and subject to the Participation Conditions in any Block Trade Offering, each Potential Takedown Participant’s Pro Rata Portion
shall be included in such Underwritten Shelf Takedown if such Potential Takedown Participant has complied with the requirements set forth in this Section 3.2.5. For any Underwritten Shelf Takedown that is not a Block Trade Offering, any
Principal Investor that has requested its Registrable Securities be included in such Underwritten Shelf Takedown pursuant to this Section 3.2.5 may withdraw all or any portion of its Registrable Securities included in an Underwritten Shelf
Takedown from such Underwritten Shelf Takedown at any time prior to the execution of the underwriting agreement related to such Underwritten Shelf Takedown. 

(c) The Company shall not be obligated to take any action to effect any Underwritten Shelf Takedown if a Demand Registration or
an Underwritten Shelf Takedown was consummated within the preceding 60 days (unless otherwise consented to by the Board of Directors of the Company); provided, however, that if a prior Underwritten Shelf Takedown was executed as a
Block Trade Offering, no such limitation shall apply. 
 Section 3.2.6. Priority of Securities Sold Pursuant to Shelf
Takedowns. If the managing underwriter or underwriters of a proposed Underwritten Shelf Takedown pursuant to Section 3.2.5 advise the Company in writing that, in its or their opinion, the number of securities requested to be included in the
proposed Underwritten Shelf Takedown exceeds the number that can be sold in such Underwritten Shelf Takedown without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the
securities offered, the number of Registrable Securities to be included in such offering shall be (x) first, for each Holder that has requested to participate in such 

  
 14 

 
Underwritten Shelf Takedown an amount equal to the lesser of (i) the number of such Registrable Securities requested to be registered or sold by such Holder, and (ii) a number of such
shares equal to such Holder’s Pro Rata Portion, and (y) second, and only if all the securities referred to in clause (x) have been included, the number of other securities that, in the opinion of such managing underwriter or
underwriters can be sold without having such adverse effect. 
 Section 3.2.7. Resale Rights. In the event that a
Principal Investor elects to request a Registration pursuant to this Section 3.2 in connection with a distribution of Registrable Securities to its partners, members or stockholders, the Registration shall provide for resale by such partners,
members or stockholders, if requested by such Principal Investor. 
 Section 3.2.8. S-3 Eligibility.
Notwithstanding the foregoing, if, at any time following the period of 12 calendar months after the Closing, the Company is not eligible to register securities on Form S-3, until the Company is eligible the Company shall be obligated to file such
additional Demand Registration Statements on Form S-1 or any similar long-form registration statements as may be necessary to effect the registration of all Registrable Securities held by the Principal Investors, in a manner to allow sales
consistent with the terms of this Section 3.2. Any such Demand Registration Statement filed pursuant to this Section 3.2.8 shall not be counted for purposes of the number of Demand Registration Requests made by the Demanding Holder that
had submitted such Demand Registration Request pursuant to Section 3.1.1(a). The meaning of the phrase “period of 12 calendar months” is intended to be consistent with the way in which the phrase “12 calendar months” is used
for purposes of the registrant eligibility requirements in Form S-3. 
 Section 3.3. Piggyback Registration.

 Section 3.3.1. Participation. If the Company at any time proposes to file a Registration Statement under the
Securities Act or to conduct a Public Offering with respect to any offering of its equity securities for its own account or for the account of any other Persons (other than an Excluded Registration), then, as soon as practicable (but in no event
less than five Business Days prior to the proposed date of filing of such Registration Statement or, in the case of any such Public Offering, the anticipated pricing or trade date), the Company shall give written notice (a “Piggyback
Notice”) of such proposed filing or Public Offering to all Holders, and such Piggyback Notice shall offer the Holders the opportunity to register under such Registration Statement, or to sell in such Public Offering, such number of
Registrable Securities as each such Holder may request in writing (a “Piggyback Registration”). Subject to Section 3.3.2, the Company shall include in such Registration Statement or in such Public Offering as applicable,
all such Registrable Securities that are requested to be included therein within three Business Days after the receipt by such Holder of any such notice; provided, however, that if at any time after giving written notice of its
intention to register or sell any securities and prior to the effective date of the Registration Statement 

  
 15 

 
filed in connection with such Registration, or the pricing or trade date of such Public Offering, the Company shall determine for any reason not to register or sell or to delay Registration or
the sale of such securities, the Company shall promptly give written notice of such determination to each Holder and, thereupon, (i) in the case of a determination not to register or sell, the Company shall be relieved of its obligation to
register or sell any Registrable Securities in connection with such Registration or Public Offering (but not from its obligation to pay the Registration Expenses in connection therewith), without prejudice, however, to the rights of any Holders
entitled to request that such Registration or sale be effected as a Demand Registration under Section 3.1 or an Underwritten Shelf Takedown under Section 3.2, as the case may be, and (ii) in the case of a determination to delay
Registration or sale, in the absence of a request for a Demand Registration or an Underwritten Shelf Takedown, as the case may be, the Company shall be permitted to delay registering or selling any Registrable Securities, for the same period as the
delay in registering or selling such other securities. If the offering pursuant to such Registration Statement or Public Offering is to be an Underwritten Public Offering, then each Holder making a request for a Piggyback Registration pursuant to
this Section 3.3.1 shall, and the Company shall, make such arrangements with the managing underwriter or underwriters so that each such Holder may, participate in such underwritten offering. If the offering pursuant to such Registration
Statement or Public Offering is to be on any other basis, then each Holder making a request for a Piggyback Registration pursuant to this Section 3.3.1 shall, and the Company shall, make such arrangements so that each such Holder may,
participate in such offering on such basis. Any Holder shall have the right to withdraw all or part of its request for inclusion of its Registrable Securities in a Piggyback Registration by giving written notice to the Company of its request to
withdraw; provided that such request must be made in writing prior to the execution of the underwriting agreement. 

Section 3.3.2. Priority of Piggyback Registration. If the managing underwriter or underwriters of any proposed
offering of Registrable Securities included in a Piggyback Registration informs the Company and the participating Holders in writing that, in its or their opinion, the number of securities that such Holders and any other Persons intend to include in
such offering exceeds the number that can be sold in such offering without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the securities to be
included in such Registration shall be (i) first, 100% of the securities that the Company or (subject to Section 3.7) any Person (other than a Holder) exercising a contractual right to demand Registration, as the case may be, proposes to
sell, and (ii) second, and only if all the securities referred to in clause (i) have been included, the number of Registrable Securities that, in the opinion of such managing underwriter or underwriters, can be sold without having such
adverse effect, with such number to be allocated among the Holders that have requested to participate in such Registration based on an amount equal to the lesser of (i) the number of such Registrable Securities requested to be sold by such
Holder, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion and (iii) third, and only if all 

  
 16 

 
of the Registrable Securities referred to in clause (ii) have been included in such Registration, any other securities eligible for inclusion in such Registration. 

Section 3.3.3. No Effect on Other Registrations. No Registration of Registrable Securities effected pursuant to a
request under this Section 3.3 shall be deemed to have been effected pursuant to Sections 3.1 and 3.2 or shall relieve the Company of its obligations under Sections 3.1 and 3.2. 

Section 3.4. Lock-Up Agreements. In connection with each Registration or sale of Registrable Securities pursuant to
Section 3.1, 3.2 or 3.3 conducted as an Underwritten Public Offering, each Holder agrees, if requested, to become bound by and to execute and deliver such lock-up agreement with the underwriter(s) of such Public Offering restricting such
Holder’s right to (a) Transfer, directly or indirectly, any Registrable Securities or (b) enter into any swap or other arrangement that transfers to another any of the economic consequences of ownership of Registrable Securities, as
is entered into by any Principal Investor with the underwriter(s) of such Public Offering; provided, however, that no Holder shall be required to enter into a lock-up agreement covering a period of greater than 90 days after the date
of the final Prospectus relating to such offering or such longer period as is agreed to by each of the Principal Investors; provided, further, that in no event shall such lock-up period be greater than the period agreed to by the
Company, its directors or officers or any other Principal Investors. Notwithstanding the foregoing, such lock-up agreement shall not apply to (i) distributions-in-kind to a Principal Investor’s partners, members or stockholders;
(ii) Transfers to Permitted Transferees of such Holder in accordance with the terms of this Agreement, in each case, only if such distributees and transferees agree to be bound by the restrictions herein; or (iii) other customary
exceptions that the underwriter(s) of such Underwritten Public Offering may agree to. 
 Section 3.5. Registration
Procedures. 
 Section 3.5.1. Requirements. In connection with the Company’s obligations under Sections
3.1, 3.2 and 3.3, the Company shall use its reasonable best efforts to effect such Registration and to permit the sale of such Registrable Securities in accordance with the intended method or methods of distribution thereof as expeditiously as
reasonably practicable, and in connection therewith the Company shall: 
 (a) as promptly as is reasonably practicable
prepare and file the required Registration Statement, including all exhibits and financial statements required under the Securities Act to be filed therewith, and, before filing a Registration Statement or Prospectus or any amendments or supplements
thereto, (x) furnish to the underwriters, if any, and to the Holders of the Registrable Securities covered by such Registration Statement, copies of all documents prepared to be filed, which documents shall be subject to the review of such
underwriters and such Holders and their respective counsel, (y) subject to applicable law, make such changes in such documents concerning the Holders prior to the filing thereof as 

  
 17 

 
such Holders, or their counsel, may reasonably request and (z) subject to applicable law, except in the case of a Registration under Section 3.3, not file any Registration Statement or
Prospectus or amendments or supplements thereto to which any participating Principal Investor, or the underwriters, if any, shall reasonably object; 

(b) as promptly as is reasonably practicable prepare and file with the SEC such amendments and post-effective amendments to
such Registration Statement and supplements to the Prospectus as may be (x) reasonably requested by any Principal Investor with Registrable Securities covered by such Registration Statement, (y) reasonably requested by any participating
Holder (to the extent such request relates to information relating to such Holder), or (z) necessary to keep such Registration Statement effective for the period of time required by this Agreement, and comply with provisions of the applicable
securities laws with respect to the sale or other disposition of all securities covered by such Registration Statement during such period in accordance with the intended method or methods of disposition by the sellers thereof set forth in such
Registration Statement; 
 (c) notify the participating Holders and the managing underwriter or underwriters, if any, and (if
requested) confirm such notice in writing and provide copies of the relevant documents, as soon as reasonably practicable after notice thereof is received by the Company (a) when the applicable Registration Statement or any amendment thereto
has been filed or becomes effective, and when the applicable Prospectus or any amendment or supplement thereto has been filed, (b) of any written comments by the SEC, or any request by the SEC or other federal or state governmental authority
for amendments or supplements to such Registration Statement or such Prospectus, or for additional information (whether before or after the effective date of the Registration Statement) or any other correspondence with the SEC relating to, or which
may affect, the Registration, (c) of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or any order by the SEC or any other regulatory authority preventing or suspending the use of any
preliminary or final Prospectus or the initiation or threatening of any proceedings for such purposes, (d) if, at any time, the representations and warranties of the Company in any applicable underwriting agreement cease to be true and correct
in all material respects and (e) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or threatening of
any proceeding for such purpose; 
 (d) promptly notify each selling Holder and the managing underwriter or underwriters, if
any, when the Company becomes aware of the happening of any event as a result of which the applicable Registration 

  
 18 

 
Statement or the Prospectus included in such Registration Statement (as then in effect) contains any untrue statement of a material fact or omits to state a material fact necessary to make the
statements therein (in the case of such Prospectus or any preliminary Prospectus, in light of the circumstances under which they were made) not misleading, when any Issuer Free Writing Prospectus includes information that may conflict with the
information contained in the Registration Statement, or, if for any other reason it shall be necessary during such time period to amend or supplement such Registration Statement or Prospectus in order to comply with the Securities Act and, as
promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish without charge to the selling Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such Registration Statement or
Prospectus, which shall correct such misstatement or omission or effect such compliance; 
 (e) to the extent the Company is
eligible under the relevant provisions of Rule 430B under the Securities Act, if the Company files any Shelf Registration Statement, the Company shall include in such Shelf Registration Statement such disclosures as may be required by Rule 430B
under the Securities Act (referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that the Holders may be added to such Shelf Registration
Statement at a later time through the filing of a Prospectus supplement rather than a post-effective amendment; 
 (f) use
its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or other order or notice preventing or suspending the use of any preliminary or final Prospectus; 

(g) promptly incorporate in a Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment such
information as the managing underwriter or underwriters and the Holders of a majority of Registrable Securities being sold agree should be included therein relating to the plan of distribution with respect to such Registrable Securities; and make
all required filings of such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such Prospectus supplement, Issuer Free
Writing Prospectus or post-effective amendment; 
 (h) furnish to each selling Holder and each underwriter, if any, without
charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment or supplement thereto, including financial statements and schedules, all
documents incorporated therein by reference and all exhibits (including those incorporated by reference); 

  
 19 

 (i) deliver to each selling Holder and each underwriter, if any, without charge,
as many copies of the applicable Prospectus (including each preliminary prospectus) and any amendment or supplement thereto and such other documents as such Holder or underwriter may reasonably request in order to facilitate the disposition of the
Registrable Securities by such Holder or underwriter (it being understood that the Company shall consent to the use of such Prospectus or any amendment or supplement thereto by each of the selling Holders and the underwriters, if any, in connection
with the offering and sale of the Registrable Securities covered by such Prospectus or any amendment or supplement thereto); 

(j) on or prior to the date on which the applicable Registration Statement becomes effective, use its reasonable best efforts
to register or qualify, and cooperate with the selling Holders, the managing underwriter or underwriters, if any, and their respective counsel, in connection with the Registration or qualification of such Registrable Securities for offer and sale
under the securities or “Blue Sky” laws of each state and other jurisdiction as any such selling Holder or managing underwriter or underwriters, if any, or their respective counsel reasonably request in writing and do any and all other
acts or things reasonably necessary or advisable to keep such Registration or qualification in effect for such period as required by Section 3.1 or Section 3.2, as applicable; provided that the Company shall not be required to
qualify generally to do business in any jurisdiction where it is not then so qualified or to take any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject; 

(k) cooperate with the selling Holders and the managing underwriter or underwriters, if any, to enable such Registrable
Securities to be in such denominations and registered in such names as the managing underwriters may request at least three Business Days prior to any sale of Registrable Securities to the underwriters; 

(l) use its reasonable best efforts to cause the Registrable Securities covered by the applicable Registration Statement to be
registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities; 

(m) not later than the effective date of the applicable Registration Statement, provide a CUSIP number for all Registrable
Securities if other than the CUSIP for the publicly traded Class A Common Stock; 
 (n) make such representations and
warranties to the Holders of Registrable Securities being registered, and the underwriters or agents, if 

  
 20 

 
any, in form, substance and scope as are customarily made by issuers in public offerings similar to the offering then being undertaken; 

(o) enter into such customary agreements (including underwriting and indemnification agreements) and take all such other
actions as any participating Principal Investor or the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate the Registration and disposition of such Registrable Securities; 

(p) obtain for delivery to the Holders being registered and to the underwriter or underwriters, if any, an opinion or opinions
from counsel for the Company dated the most recent effective date of the Registration Statement or, in the event of an Underwritten Public Offering, the date of the closing under the underwriting agreement, in customary form, scope and substance,
which opinions shall be reasonably satisfactory to such Holders or underwriters, as the case may be, and their respective counsel; 

(q) in the case of an Underwritten Public Offering, obtain for delivery to the Company and the managing underwriter or
underwriters, with copies to the Holders included in such Registration or sale, a comfort letter from the Company’s independent certified public accountants or independent auditors (and, if necessary, any other independent certified public
accountants or independent auditors of any subsidiary of the Company or any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) in customary form and
covering such matters of the type customarily covered by comfort letters as the managing underwriter or underwriters reasonably request, dated the date of execution of the underwriting agreement and brought down to the closing under the underwriting
agreement; 
 (r) cooperate with each seller of Registrable Securities and each underwriter, if any, participating in the
disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 

(s) use its reasonable best efforts to comply with all applicable securities laws and, if a Registration Statement was filed,
make available, including through the SEC’s EDGAR filing system or any successor system, to its security holders, as soon as reasonably practicable, an earnings statement satisfying the provisions of Section 11(a) of the Securities Act and
the rules and regulations promulgated thereunder; 
 (t) provide and cause to be maintained a transfer agent and registrar
for all Registrable Securities covered by the applicable 

  
 21 

 
Registration Statement from and after a date not later than the effective date of such Registration Statement; 

(u) use its reasonable best efforts to cause all Registrable Securities covered by the applicable Registration Statement to be
listed on the securities exchange on which the Company’s Class A Common Stock is then listed or quoted and on each inter-dealer quotation system on which the Company’s Class A Common Stock is then quoted; 

(v) make available upon reasonable notice at reasonable times and for reasonable periods for inspection by a representative
appointed by the majority of the Holders covered by the applicable Registration Statement, by any underwriter participating in any disposition to be effected pursuant to such Registration Statement and by any attorney, accountant or other agent
retained by such Holders or any such underwriter, all pertinent financial and other records and pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors and employees and the independent
public accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply all information reasonably requested by any such Person in connection with such Registration Statement;

 (w) in the case of a marketed Public Offering, cause the senior executive officers of the Company to participate in the
customary “road show” presentations that may be reasonably requested by the managing underwriter or underwriters in any such offering and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated
herein and customary selling efforts related thereto; 
 (x) take no direct or indirect action prohibited by Regulation M
under the Exchange Act; 
 (y) take all reasonable action to ensure that any Issuer Free Writing Prospectus utilized in
connection with any Registration complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required
thereby and, when taken together with the related Prospectus, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading; and 
 (z) take all such other reasonable actions as are necessary or advisable in order to expedite or
facilitate the disposition of such Registrable Securities in accordance with the terms of this Agreement. 

  
 22 

 Section 3.5.2. Company Information Requests. The Company may require
each seller of Registrable Securities as to which any Registration or sale is being effected to furnish to the Company such information regarding the distribution of such securities and such other information relating to such Holder and its
ownership of Registrable Securities as the Company may from time to time reasonably request in writing and the Company may exclude from such Registration or sale the Registrable Securities of any such Holder who unreasonably fails to furnish such
information within a reasonable time after receiving such request. Each Holder agrees to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this
Agreement. 
 Section 3.5.3. Discontinuing Registration. Each Holder agrees that, as promptly as possible after
receipt of any notice from the Company of the happening of any event of the kind described in Section 3.5.1(d), such Holder will forthwith discontinue disposition of Registrable Securities pursuant to such Registration Statement until such
Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d), or until such Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and has received copies of
any additional or supplemental filings that are incorporated by reference in the Prospectus, or any amendments or supplements thereto, and if so directed by the Company, such Holder shall deliver to the Company (at the Company’s expense) all
copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice. In the event the Company shall give any such notice, the period
during which the applicable Registration Statement is required to be maintained effective shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the date when each seller
of Registrable Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d) or is advised in writing by the Company that the use of the Prospectus may be
resumed. 
 Section 3.6. Underwritten Offerings. 

Section 3.6.1. Shelf and Demand Registrations. If requested by the underwriters for any Underwritten Public
Offering, pursuant to a Registration or sale under Section 3.1 or 3.2, the Company shall enter into an underwriting agreement with such underwriters, such agreement to be reasonably satisfactory in substance and form to each of the Company,
each Principal Investor seeking to participate in such offering and the underwriters, and to contain such representations and warranties by the Company and such other terms as are generally prevailing in agreements of that type. The Holders of the
Registrable Securities proposed to be distributed by such underwriters shall cooperate with the Company in the negotiation of the underwriting agreement and shall give consideration to the reasonable suggestions of the Company regarding the form

  
 23 

 
thereof. Such Holders to be distributed by such underwriters shall be parties to such underwriting agreement, which underwriting agreement shall contain such representations and warranties by,
and the other agreements on the part of, the Company to and for the benefit of such Holders as are customarily made by issuers to selling stockholders in public offerings similar to the applicable offering. Any such Holder shall be required to make
representations and warranties and other agreements, deliver an opinion or opinions from its counsel and provide indemnities, in each case as are customarily made by selling stockholders in secondary public offerings. 

Section 3.6.2. Piggyback Registrations. If the Company proposes to register or sell any of its securities under the
Securities Act as contemplated by Section 3.3 and such securities are to be distributed through one or more underwriters, the Company shall, if requested by any Holder pursuant to Section 3.3 and, subject to the provisions of
Section 3.3.2, use its reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers in such Registration or sale all the Registrable Securities to be offered and sold by
such Holder among the securities of the Company to be distributed by such underwriters in such Registration or sale. The Holders of Registrable Securities to be distributed by such underwriters shall be parties to the underwriting agreement between
the Company and such underwriters, which underwriting agreement shall contain such representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such Holders as are customarily made by issuers to
selling stockholders in secondary public offerings. Any such Holder shall be required to make representations and warranties and other agreements, deliver an opinion or opinions from its counsel and provide indemnities, in each case as are
customarily made by selling stockholders in secondary public offerings. 
 Section 3.6.3. Participation in
Underwritten Registrations. Subject to the provisions of Section 3.6.1 and Section 3.6.2 above, no Person may participate in any Underwritten Public Offering hereunder unless such Person (i) agrees to sell such Person’s
securities on the basis provided in any underwriting arrangements approved by the Persons entitled to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and
other documents required under the terms of such underwriting arrangements; provided that any such Holder shall not be required to make any representations or warranties to or agreements with the Company other than representations, warranties
or agreements regarding such Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method of distribution and any other representations to be made by the Holder as are generally prevailing in agreements of that
type. 
 Section 3.6.4. Selection of Underwriters. In the case of an Underwritten Public Offering under
Section 3.1 or 3.2, the managing underwriter or underwriters to administer the offering shall be determined by the Holders of a majority of Registrable Securities to be included in such Underwritten Public

  
 24 

 
Offering; provided that such managing underwriter or underwriters shall be reasonably acceptable to the Company. 

Section 3.7. No Inconsistent Agreements; Additional Rights. Neither the Company nor any of its subsidiaries shall hereafter enter
into, and neither the Company nor any of its subsidiaries is currently a party to, any agreement with respect to its securities that is inconsistent with the rights granted to the Holders by this Agreement. Without Requisite Investor Approval,
neither the Company nor any of its subsidiaries shall enter into any agreement granting registration or similar rights to any Person that are prior in right, pari passu or inconsistent with the rights under this Agreement, and the Company hereby
represents and warrants that, as of the date hereof, no registration or similar rights have been granted to any other Person other than pursuant to this Agreement. 

Section 3.8. Registration Expenses. All expenses incident to the Company’s performance of or compliance with this Agreement
shall be paid by the Company, including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC or FINRA, (ii) all fees and expenses in connection with compliance with
any securities or “Blue Sky” laws (including reasonable fees and disbursements of counsel for the underwriters in connection with blue sky qualifications of the Registrable Securities), (iii) all printing, duplicating, word
processing, messenger, telephone, facsimile and delivery expenses of the Company (including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing
Prospectuses), (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants or independent auditors of the Company and any subsidiaries of the Company (including the expenses of any special
audit and comfort letters required by or incident to such performance), (v) Securities Act liability insurance or similar insurance if the Company so desires, (vi) all fees and expenses incurred in connection with the listing of the
Registrable Securities on any securities exchange or quotation of the Registrable Securities on any inter-dealer quotation system, (vii) all applicable rating agency fees with respect to the Registrable Securities, (viii) all reasonable
fees and disbursements of one counsel for each Principal Investor to the extent that they participate in such Registration or sale, (ix) all fees and expenses of any special experts or other Persons retained by the Company in connection with
any Registration or sale, (x) all of the Company’s internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties) and (xi) all expenses of the Company related to the
“road-show” for any Underwritten Public Offering. All such expenses are referred to herein as “Registration Expenses”. The Company shall not be required to pay any fees and disbursements to underwriters not customarily
paid by the issuers of securities in an offering similar to the applicable offering, including underwriting discounts and commissions and transfer taxes, if any, attributable to the sale of Registrable Securities, which shall be paid by the
participating Holders in proportion to the number of Registrable Securities offered and sold by or on behalf of each such Holder. 

Section 3.9. Indemnification. 

  
 25 

 Section 3.9.1. Indemnification by the Company. The Company shall, and
it hereby does, indemnify and hold harmless, to the fullest extent permitted by law, each Holder, its officers, directors, partners, members, managers, stockholders and employees and each Person who controls (within the meaning of the Securities Act
or the Exchange Act) such Persons from and against any and all losses, claims, damages, liabilities and expenses, joint or several (including reasonable costs of investigation and reasonable legal expenses or other reasonable expenses actually
incurred thereby in connection with investigating or defending any claim or proceeding resulting therefrom) (each, a “Loss” and collectively “Losses”) arising out of or based upon (i) any untrue or alleged
untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities are registered or sold under the Securities Act (including any final, preliminary or summary Prospectus contained therein or any
amendment thereof or supplement thereto or any documents incorporated by reference therein) or any other disclosure document produced by or on behalf of the Company or any of its subsidiaries including any report and other document filed under the
Exchange Act, (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances
under which they were made) not misleading; provided, that no selling Holder shall be entitled to indemnification pursuant to this Section 3.9.1 in respect of any untrue statement or omission contained in any information furnished in
writing by such selling Holder to the Company specifically for inclusion in a Registration Statement that has not been corrected in a subsequent writing prior to the sale of the Registrable Securities to the Person asserting the claim or
(iii) any violation or alleged violation by the Company (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or
any state securities law. This indemnity shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder or any
indemnified party and shall survive the Transfer of such securities by such Holder. The Company shall also indemnify underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution,
their officers and directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the same extent as provided above with respect to the indemnification of the indemnified parties. 

Section 3.9.2. Indemnification by the Selling Holders. Each selling Holder agrees (severally and not jointly) to
indemnify and hold harmless, to the fullest extent permitted by law, the Company, its directors, officers, partners, members, managers, stockholders and employees and each Person who controls the Company (within the meaning of the Securities Act or
the Exchange Act) from and against any Losses resulting from (i) any untrue statement of a material fact in any Registration Statement under which such Registrable Securities were registered or sold under the Securities Act (including any
final, preliminary or 

  
 26 

 
summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or (ii) any omission to state therein a material fact
required to be stated therein or necessary to make the statements therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case to the extent, but only to the
extent, that such untrue statement or omission is contained in any information about such Holder furnished in writing by such selling Holder to the Company specifically for inclusion in such Registration Statement and has not been corrected in a
subsequent writing prior to or concurrently with the sale of the Registrable Securities to the Person asserting the claim. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net
proceeds received by such Holder under the sale of Registrable Securities giving rise to such indemnification obligation less any amounts paid by such Holder pursuant to Section 3.9.4 and any amounts paid by such Holder as a result of
liabilities incurred under the underwriting agreement, if any, related to such sale. The Company shall be entitled to receive indemnities from underwriters, selling brokers, dealer managers and similar securities industry professionals participating
in the distribution, to the same extent as provided above (with appropriate modification) with respect to information furnished in writing by such Persons specifically for inclusion in any Prospectus or Registration Statement. 

Section 3.9.3. Conduct of Indemnification Proceedings. Any Person entitled to indemnification hereunder shall
(i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that any delay or failure to so notify the indemnifying party shall relieve the indemnifying party of its
obligations hereunder only to the extent, if at all, that it is actually and materially prejudiced by reason of such delay or failure) and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party; provided, however, that any Person entitled to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense of such claim, but the fees
and expenses of such counsel shall be at the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the indemnifying party shall have failed to assume the defense of such claim
within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified party has reasonably concluded (based upon
advice of its counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, or (iv) in the reasonable judgment of any such Person
(based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ
separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the indemnifying party

  
 27 

 
shall not have the right to settle such action without the prior written consent of the indemnified party. No indemnifying party shall consent to entry of any judgment or enter into any
settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of an unconditional release from all liability in respect to such claim or litigation without the prior written
consent of such indemnified party. If such defense is not assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not be
unreasonably withheld or delayed. Notwithstanding the foregoing, if at any time an indemnified party shall have requested that an indemnifying party reimburse the indemnified party for reasonable fees and expenses of counsel as contemplated by this
paragraph, the indemnifying party shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into in good faith more than 60 days after receipt by the indemnifying party of such
request and more than 30 days after receipt of the proposed terms of such settlement and (ii) the indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. It is
understood that the indemnifying party or parties shall not, except as specifically set forth in this Section 3.9.3, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees,
disbursements or other charges of more than one separate firm admitted to practice in such jurisdiction. 

Section 3.9.4. Contribution. If for any reason the indemnification provided for in Section 3.9.1 and
Section 3.9.2 is unavailable to an indemnified party (other than as a result of exceptions contained in Section 3.9.1 and Section 3.9.2) or insufficient in respect of any Losses referred to therein, then the indemnifying party shall
contribute to the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and the indemnified party or parties on the other
hand in connection with the acts, statements or omissions that resulted in such Losses, as well as any other relevant equitable considerations. In connection with any Registration Statement filed with the SEC by the Company, the relative fault of
the indemnifying party on the one hand and the indemnified party on the other hand shall be determined by reference to, among other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The
parties hereto agree that it would not be just or equitable if contribution pursuant to this Section 3.9.4 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in this Section 3.9.4. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. The amount paid or payable by an indemnified party as a result of the Losses referred 

  
 28 

 
to in Sections 3.9.1 and 3.9.2 shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim. If indemnification is available under this Section 3.9, the indemnifying parties shall indemnify each indemnified party to the fullest extent provided in Sections 3.9.1 and 3.9.2 hereof
without regard to the provisions of this Section 3.9.4. The remedies provided for in this Section 3.9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in
equity. Notwithstanding the provisions of this Section 3.9.4, in connection with any Registration Statement filed by the Company, a selling Holder shall not be required to contribute any amount in excess of the dollar amount of the net proceeds
received by such holder under the sale of Registrable Securities giving rise to such contribution obligation less any amounts paid by such Holder pursuant to Section 3.9.2 and any amounts paid by such Holder as a result of liabilities incurred
under the underwriting agreement, if any, related to such sale. 
 Section 3.10. Rules 144 and 144A and Regulation S. The
Company shall file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request
of any Holder, make publicly available such necessary information for so long as necessary to permit sales that would otherwise be permitted by this Agreement pursuant to Rule 144, Rule 144A or Regulation S under the Securities Act, as such Rules
may be amended from time to time or any similar rule or regulation hereafter adopted by the SEC), and it will take such further action as any Holder may reasonably request, including the delivery of customary opinions requested to effectuate such
sales pursuant to Rule 144, all to the extent required from time to time to enable such Holder to sell Registrable Securities without Registration under the Securities Act in transactions that would otherwise be permitted by this Agreement and
within the limitation of the exemptions provided by (i) Rules 144, 144A or Regulation S under the Securities Act, as such rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the
request of any Holder, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof. 

Section 3.11. Existing Registration Statements. Notwithstanding anything herein to the contrary and subject to applicable law and
regulation, the Company may satisfy any obligation hereunder to file a Registration Statement or to have a Registration Statement become effective by a specified date by designating, by notice to the Holders, a Registration Statement that previously
has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying such obligation, and all references to any such obligation shall be construed accordingly; provided that
such previously filed Registration Statement may be amended or, subject to applicable securities laws, supplemented to add the number of Registrable Securities, and, to the extent necessary, to identify as selling stockholders those Holders
demanding the filing of a Registration Statement pursuant to the terms of this Agreement. To the extent this Agreement refers to the filing or effectiveness of other Registration 

  
 29 

 
Statements, by or at a specified time and the Company has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously
filed or effective Registration Statement as the relevant Registration Statement for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended. 

ARTICLE IV 
 Miscellaneous

 Section 4.1. Authority: Effect. Each party hereto represents and warrants to and agrees with each other party that the
execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any agreement or other instrument applicable to such party or by which its
assets are bound. This Agreement does not, and shall not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint venture or other association. The Company
and its subsidiaries shall be jointly and severally liable for all obligations of each such party pursuant to this Agreement. 

Section 4.2. Notices. Any notices, requests, demands and other communications required or permitted in this Agreement shall be
effective if in writing and (i) delivered personally, (ii) sent by facsimile or e-mail, or (iii) sent by overnight courier, in each case, addressed as follows: 

if to the Company, to: 

Evolent Health, Inc. 
 800 N.
Glebe Road, Suite 500 
 Arlington, VA 22203 

			
	Attention:		Jonathan Weinberg,
			General Counsel
	Facsimile:		(571) 389-6001
	E-mail:		jweinberg@evolenthealth.com

 with a copy (which shall not constitute notice) to: 

Cravath, Swaine & Moore LLP 

825 Eighth Avenue 
 New York,
New York 10019 

			
	Attention:		William V. Fogg
	Facsimile:		(212) 474-1000
	E-mail:		wfogg@cravath.com

  
 30 

 if to the TPG Investor, to: 

TPG Global, LLC 
 301 Commerce
Street, Suite 3300 
 Fort Worth, Texas 76102 

			
	Attention:		General Counsel
	Facsimile:		(415) 743-1501

 with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 

Three Embarcadero Center 
 San
Francisco, California 94111 

			
	Attention:		Thomas Holden, Esq.
	Facsimile:		(415) 315-4823
	E-mail:		thomas.holden@ropesgray.com

 if to The Advisory Board Investor, to: 

The Advisory Board Company 

2445 M St., NW 
 Washington,
D.C. 20037 

			
	Attention:		Evan Farber
	Facsimile:		(202) 266-5700
	E-mail:		farbere@advisory.com

 with a copy (which shall not constitute notice) to: 

Skadden, Arps, Slate, Meagher & Flom LLP 

			
	Attention:		Jeremy D. London
	Facsimile:		(202) 661-8299
	E-mail:		Jeremy.London@skadden.com

 if to the UPMC Investor, to: 

UPMC 
 U.S. Steel Building 

600 Grant Street, 55th Floor 

Pittsburgh, Pennsylvania 15219 

			
	Attention:		Chief Legal Officer
	Facsimile:		(412) 647-9193

 with a copy (which shall not constitute notice) to: 

Drinker Biddle & Reath LLP 

1500 K Street, N.W. 

Washington, D.C. 20005-1209 

  
 31 

			
	Attention:		Gerald McCartin
	Facsimile:		(202) 842-8465
	E-mail:		Gerald.McCartin@dbr.com

 if to the Ptolemy Investor, to: 

Ptolemy Capital, LLC 
 1250
Prospect St, Suite 200 
 La Jolla, California 92037 

			
	Attention:		Michael R. Stone
	Facsimile:		(858) 551-1175
	E-mail:		mike@fsinvestors.com and mitch@fsinvestors.com

 Notice to the holder of record of any Registrable Securities shall be deemed to be notice to the holder of
such securities for all purposes hereof. 
 Unless otherwise specified herein, such notices or other communications shall be deemed
effective (i) on the date received, if personally delivered, (ii) on the date received if delivered by facsimile or e-mail on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter and (iii) two
Business Days after being sent by overnight courier. Each of the parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

Section 4.3. Termination and Effect of Termination. This Agreement shall terminate upon the date on which no Holder holds any
Registrable Securities, except for the provisions of Sections 3.9 and 3.10, which shall survive any such termination. No termination under this Agreement shall relieve any Person of liability for breach prior to termination. In the event this
Agreement is terminated, each Person entitled to indemnification rights pursuant to Section 3.9 hereof shall retain such indemnification rights with respect to any matter that (i) may be an indemnified liability thereunder and
(ii) occurred prior to such termination. 
 Section 4.4. Permitted Transferees. The rights of a Holder hereunder may be
assigned (but only with all related obligations as set forth below) in connection with a Transfer of Class B common units, shares of Class B Common Stock or Registrable Securities effected in accordance with the terms of the Third Amended and
Restated Operating Agreement of Evolent Health LLC and this Agreement to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions imposed hereunder with respect to any such Transfer, no assignment permitted under
the terms of this Section 4.4 will be effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written acknowledgment and agreement in form and substance reasonably
satisfactory to the Company that the Permitted Transferee will be bound by, and will be a party to, this Agreement. A Permitted Transferee to whom rights are transferred pursuant to this Section 4.4 may not again transfer those rights to any
other Permitted Transferee, other than as provided in this Section 4.4. 

  
 32 

 Section 4.5. Remedies. The parties to this Agreement shall have all remedies
available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other remedies that
may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies (including preliminary or temporary relief) as may be
appropriate in the circumstances. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other party under this Agreement shall impair any such right, power or remedy,
nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single breach or default be deemed a waiver of any
other breach or default occurring before or after that waiver. 
 Section 4.6. Amendments. This Agreement may not be orally
amended, modified, extended or terminated, nor shall any oral waiver of any of its terms be effective. This Agreement may be amended, modified, extended or terminated, and the provisions hereof may be waived, only by an agreement in writing signed
by the Company and each of the Principal Investors. Each such amendment, modification, extension or termination shall be binding upon each party hereto and each Other Holder; provided that no such amendment, modification, extension or
termination shall be binding upon any party hereto unless agreed to in writing by such party. In addition, each party hereto may waive any right hereunder by an instrument in writing signed by such party. 

Section 4.7. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject
matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of New York without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic
substantive laws of any other jurisdiction. 
 Section 4.8. Consent to Jurisdiction. Each party to this Agreement, by its
execution hereof, (i) hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of New York for the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise),
inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof, (ii) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any
of its subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that any such proceeding brought in one of the above-named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced in or by such court and (iii) hereby agrees not to commence or maintain
any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof or thereof other than before one of the
above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of 

  
 33 

 
any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any court other than one of the above-named courts whether on the grounds
of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party hereto is or becomes a party in any litigation in connection with which it may assert indemnification rights set forth in this Agreement, the court in
which such litigation is being heard shall be deemed to be included in clause (i) above. Notwithstanding the foregoing, any party to this Agreement may commence and maintain an action to enforce a judgment of any of the above-named courts in
any court of competent jurisdiction. Each party hereto hereby consents to service of process in any such proceeding in any manner permitted by New York law, and agrees that service of process by registered or certified mail, return receipt
requested, at its address specified pursuant to Section 4.2 hereof is reasonably calculated to give actual notice. 
 Section 4.9.
WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN
ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH
OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 4.9 CONSTITUTES A
MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 4.9 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY
TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 
 Section 4.10. Merger; Binding Effect, Etc. This Agreement (along with the
Exchange Agreement) constitutes the entire agreement of the parties with respect to its subject matter, supersedes all prior or contemporaneous oral or written agreements or discussions with respect to such subject matter, and shall be binding upon
and inure to the benefit of the parties hereto and thereto and their respective heirs, representatives, successors and permitted assigns. Except as otherwise expressly provided herein, no Holder or other party hereto may assign any of its respective
rights or delegate any of its respective obligations under this Agreement without the prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of the foregoing shall be null and void. 

Section 4.11. Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original,
but all of which taken together shall constitute one instrument. 

  
 34 

 Section 4.12. Severability. In the event that any provision hereof would, under
applicable law, be invalid or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under, applicable law. The provisions
hereof are severable, and in the event any provision hereof should be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision hereof. 

Section 4.13. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each
Holder covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, general or limited
partner or member of any Holder or of any Affiliate or assignee thereof, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being
expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future officer, agent or employee of any Holder or any current or future member of any Holder or any
current or future director, officer, employee, partner or member of any Holder or of any Affiliate or assignee thereof, as such, for any obligation of any Holder under this Agreement or any documents or instruments delivered in connection with this
Agreement for any claim based on, in respect of or by reason of such obligations or their creation. 
 [Signature pages
follow] 

  
 35 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement (or caused
this Agreement to be executed on its behalf by its officer or representative thereunto duly authorized) under seal as of the date first above written. 
  

			
	EVOLENT HEALTH, INC.
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	TPG GROWTH II BDH, L.P.
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	TPG EAGLE HOLDINGS, L.P.
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	UPMC
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	THE ADVISORY BOARD COMPANY
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	PTOLEMY CAPITAL, LLC
		
	By:		  

	Name:		
	Title:		

  
 [Signature Page to
Registration Rights Agreement]EX-10.1

 Exhibit 10.1 

SECOND AMENDED AND RESTATED 

OPERATING AGREEMENT 
 OF

 EVOLENT HEALTH LLC 

a Delaware limited liability company 

as of January 6, 2014 

THE UNITS REPRESENTED BY THIS DOCUMENT HAVE NOT BEEN REGISTERED UNDER ANY SECURITIES LAWS AND THE TRANSFERABILITY OF SUCH UNITS IS RESTRICTED
PURSUANT TO THE TERMS AND CONDITIONS OF THE COMPANY’S OPERATING AGREEMENT DATED AS OF JANUARY 6, 2014. A UNIT MAY NOT BE SOLD, ASSIGNED OR TRANSFERRED, NOR WILL ANY ASSIGNEE, VENDEE, TRANSFEREE OR ENDORSEE THEREOF BE RECOGNIZED AS HAVING
ACQUIRED ANY SUCH UNIT BY THE ISSUER FOR ANY PURPOSES, UNLESS (1) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT WITH RESPECT TO SUCH UNIT WILL THEN BE IN EFFECT AND SUCH TRANSFER HAS BEEN QUALIFIED TO THE EXTENT REQUIRED UNDER ANY
APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION AND QUALIFICATION WILL BE AVAILABLE. 
 THE UNITS
REPRESENTED BY THIS DOCUMENT ARE ALSO SUBJECT TO ADDITIONAL REPURCHASE RESTRICTIONS AND RESTRICTIONS ON TRANSFER AS SET FORTH IN AN AMENDED AND RESTATED MASTER INVESTORS’ RIGHTS AGREEMENT DATED AS OF JANUARY 6, 2014, AS MAY BE AMENDED FROM TIME
TO TIME A COPY OF WHICH WILL BE FURNISHED BY EVOLENT HEALTH LLC UPON REQUEST. 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
		
	 SECTION 1         THE COMPANY
	  			
			
	 1.1
	 	 Formation
	  	 	2	  
			
	 1.2
	 	 Company Name
	  	 	2	  
			
	 1.3
	 	 Purpose and Scope
	  	 	2	  
			
	 1.4
	 	 Principal Places of Business
	  	 	2	  
			
	 1.5
	 	 Term
	  	 	2	  
			
	 1.6
	 	 Filings; Registered Agent for Service of Process; Registered Office
	  	 	2	  
			
	 1.7
	 	 Defined Terms
	  	 	3	  
			
	 1.8
	 	 No State Law Partnership; No Liability to Third Parties
	  	 	3	  
		
	 SECTION 2         MEMBERS AND UNITS
	  			
			
	 2.1
	 	 Authorized Units
	  	 	3	  
			
	 2.2
	 	 Names, Addresses and Units of Members
	  	 	4	  
			
	 2.3
	 	 Voting Rights
	  	 	4	  
			
	 2.4
	 	 Conversion of Preferred Units; Adjustments for Diluting Issuances
	  	 	7	  
		
	 SECTION 3         CAPITAL CONTRIBUTIONS
	  			
			
	 3.1
	 	 Capital Contributions
	  	 	15	  
			
	 3.2
	 	 Other Matters
	  	 	15	  
			
	 3.3
	 	 Member Loans
	  	 	15	  
			
	 3.4
	 	 Issuance of Additional Equity Securities
	  	 	15	  
			
	 3.5
	 	 Holdco Contributions
	  	 	16	  
		
	 SECTION 4         CAPITAL ACCOUNTS AND ALLOCATIONS
	  			
			
	 4.1
	 	 Capital Accounts
	  	 	16	  
			
	 4.2
	 	 Allocation of Profits and Losses
	  	 	16	  

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
		
	 SECTION 5         DISTRIBUTIONS; TAX MATTERS
	  			
			
	 5.1
	 	 Tax Distributions
	  	 	17	  
			
	 5.2
	 	 Distributions
	  	 	18	  
			
	 5.3
	 	 Liquidation or Sale of the Company Distributions
	  	 	19	  
			
	 5.4
	 	 Preparation of Tax Returns; Tax Information
	  	 	21	  
			
	 5.5
	 	 Tax Matters Member; Tax Elections
	  	 	21	  
		
	 SECTION 6         MANAGEMENT AND CONTROL
	  			
			
	 6.1
	 	 Management by the Board
	  	 	22	  
			
	 6.2
	 	 Board Composition and Administration
	  	 	22	  
			
	 6.3
	 	 Meetings of the Board
	  	 	22	  
			
	 6.4
	 	 Notice of Board Meetings
	  	 	23	  
			
	 6.5
	 	 Waiver of Notice
	  	 	23	  
			
	 6.6
	 	 Action Without Formal Meeting
	  	 	23	  
			
	 6.7
	 	 Agents
	  	 	23	  
			
	 6.8
	 	 Officers and Employees
	  	 	23	  
			
	 6.9
	 	 Fiduciary Duties
	  	 	24	  
			
	 6.10
	 	 Disclaimer of Certain Duties
	  	 	24	  
		
	 SECTION 7         BOOKS AND RECORDS
	  			
			
	 7.1
	 	 Books and Records
	  	 	26	  
			
	 7.2
	 	 Taxable Year
	  	 	27	  
		
	 SECTION 8         ADMISSION OF MEMBERS
	  			
			
	 8.1
	 	 Prohibited Transfers
	  	 	27	  

  
 -ii- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
			
	 8.2
	 	 Conditions to Transfers
	  	 	27	  
			
	 8.3
	 	 Effect of Transfers
	  	 	28	  
			
	 8.4
	 	 Admission of Members
	  	 	29	  
			
	 8.5
	 	 Representations; Legend
	  	 	29	  
		
	 SECTION 9         LIQUIDATION OF THE COMPANY
	  			
			
	 9.1
	 	 Liquidation Events
	  	 	30	  
			
	 9.2
	 	 Winding Up
	  	 	30	  
			
	 9.3
	 	 Deficit Capital Accounts
	  	 	31	  
			
	 9.4
	 	 Reserves
	  	 	31	  
			
	 9.5
	 	 Rights of Members
	  	 	31	  
			
	 9.6
	 	 Prohibition on Withdrawal
	  	 	31	  
		
	 SECTION 10         AMENDMENTS
	  			
			
	 10.1
	 	 Authority to Amend
	  	 	31	  
			
	 10.2
	 	 Notice of Amendments
	  	 	32	  
		
	 SECTION 11         MISCELLANEOUS
	  			
			
	 11.1
	 	 Notices
	  	 	32	  
			
	 11.2
	 	 Binding Effect
	  	 	32	  
			
	 11.3
	 	 Construction
	  	 	32	  
			
	 11.4
	 	 Significant Securityholders
	  	 	32	  
			
	 11.5
	 	 Entire Agreement
	  	 	32	  
			
	 11.6
	 	 Headings
	  	 	32	  
			
	 11.7
	 	 Severability
	  	 	33	  

  
 -iii- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
			
	 11.8
	 	 Incorporation by Reference
	  	 	33	  
			
	 11.9
	 	 Further Action
	  	 	33	  
			
	 11.10
	 	 Variation of Pronouns
	  	 	33	  
			
	 11.11
	 	 Governing Law
	  	 	33	  
			
	 11.12
	 	 Specific Performance
	  	 	33	  
			
	 11.13
	 	 Tax Classification
	  	 	33	  
			
	 11.14
	 	 Counterpart Execution
	  	 	34	  
			
	 11.15
	 	 Venue and Attorney’s Fees
	  	 	34	  
			
	 11.16
	 	 Waiver of Jury Trial
	  	 	34	  

  
 -iv- 

 SECOND AMENDED AND RESTATED 

OPERATING AGREEMENT 
 OF

 EVOLENT HEALTH LLC 

a Delaware limited liability company 

THIS SECOND AMENDED AND RESTATED OPERATING AGREEMENT (this “Agreement”) of Evolent Health LLC, a Delaware limited liability
company (“the Company”), is entered into as of January 6, 2014 (the “Effective Date”), by the Persons listed on Exhibit A under the caption “Common Members” (each, a “Common
Member” and collectively the “Common Members”) and the Persons listed under the caption “Series A Preferred Members” (each, a “Series A Preferred Member,” and collectively the “Series A
Preferred Members”) the Persons listed under the caption “Series B Preferred Members” (each, a “Series B Preferred Member,” collectively the “Series B Preferred Members”) and the Persons listed
under the caption “Series B-1 Preferred Member” (each, a “Series B-1 Preferred Member” and collectively, the “Series B-1 Preferred Members,” and together with the Common Members, the Series A
Preferred Members and the Series B Preferred Members, the “Members”). 
 WHEREAS, the Company was formed under the
name “Evolent Health LLC” on September 23, 2013, pursuant to Title 6, Chapter 18 of the Delaware Limited Liability Company Act, as the same may be amended from time to time (the “LLC Law”). 

WHEREAS, the Members of the Company identified therein entered into that certain Amended and Restated Operating Agreement of the
Company effective as of September 23, 2013 (the “Operating Agreement”). 
 WHEREAS, the Company, Evolent Health
Holdings, Inc., a Delaware corporation (“Holdco”), certain of the Members and certain of the stockholders of Holdco have entered into that certain Master Investors’ Rights Agreement, dated on September 23, 2013 (as such
agreement may be amended from time to time, the “Master Rights Agreement”), which sets forth the rights and obligations of the parties thereto, including with respect to matters in connection with the ownership of the securities of
the Company and Holdco. 
 WHEREAS, prior to the execution of the Operating Agreement, the Company, Holdco and Evolent Health, Inc.,
a Delaware corporation (the “Predecessor Evolent”), completed a restructuring, pursuant to which the Predecessor Evolent merged with and into the Company, and pursuant to which the Company assumed all the rights and obligations of
the Predecessor Evolent in a transaction intended to qualify as a tax-free reorganization of the Predecessor Evolent into Holdco described in section 368(a)(1)(F) of the Code. 

WHEREAS, the parties hereto have agreed upon the terms and conditions that will govern their relationship and wish to reduce such
agreement to writing and to amend and restate the Operating Agreement in its entirety as set forth herein. 

 NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants
and agreements set forth herein, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

SECTION 1 
 THE COMPANY

 1.1 Formation. The Certificate of Formation (the “Certificate”) of the Company was filed with the Secretary
of State of the State of Delaware on September 3, 2013. The rights, powers, duties and obligations of the Members, and the management, operations and activities of the Company, shall be governed by this Agreement. 

1.2 Company Name. The name of the Company is “Evolent Health LLC.” The Company’s business may be conducted under
its name and/or any other name or names deemed advisable by the Board. 
 1.3 Purpose and Scope. Within the meaning and
for purposes of the LLC Law, the purpose and scope of the Company shall include any lawful action or activity permitted to a limited liability company under the LLC Law, as determined by the Board; provided, however, that the
Company’s initial principal purpose shall be to continue the business of the Predecessor Evolent (the “Business”). 

1.4 Principal Places of Business. The initial principal place of business of the Company shall be located at 800 N. Glebe Rd.,
Suite 500, Arlington, VA 22203. The principal place of business of the Company may be relocated from time to time by determination of the Board and notification of any such change shall be given to all Members. The Company may maintain offices at
such other place or places as the Board deems advisable. 
 1.5 Term. The term of the Company commenced upon the filing
of the Certificate in accordance with the LLC Law and shall continue in existence for perpetuity, unless dissolved or terminated pursuant to law or the provisions of this Agreement. 

1.6 Filings; Registered Agent for Service of Process; Registered Office. 

(a) Certificate. The Certificate has been filed in the office of the Secretary of State of Delaware in accordance with the provisions of
the LLC Law. 
 (b) Foreign Qualifications. The Board will take any and all other actions as may be reasonably necessary to perfect
and maintain the status of the Company as a limited liability company or similar type of entity under the laws of any states or jurisdictions other than Delaware in which the Company engages in business. 

(c) Registered Agent. The name and address of the Company’s registered agent for service of process of the Company in the State of
Delaware shall be Corporation Service Company, 2711 Centerville Road, Suite 400, City of Wilmington, New Castle County, Delaware 19808-1646. The Board may change, at any time and from time to time, such registered agent. 

  
 2 

 (d) Registered Office. The Company’s registered office in the State of Delaware shall
be Corporation Service Company, 2711 Centerville Road, Suite 400, City of Wilmington, New Castle County, Delaware 19808-1646. The Board may change, at any time and from time to time, such registered office. 

(e) Dissolution. Upon the dissolution of the Company, the Board will promptly execute and cause to be filed a certificate of
dissolution in accordance with the LLC Law and the law of any other states or jurisdictions in which the Company has qualified to conduct business. 

1.7 Defined Terms. Unless the context otherwise requires or unless otherwise provided in this Agreement, capitalized terms used
in this Agreement shall have the meanings given to them as set forth in Exhibit B to this Agreement. 
 1.8 No State
Law Partnership; No Liability to Third Parties. The Members intend that the Company not be a partnership (including, without limitation, a limited partnership) or joint venture, and that no Member be a partner or joint venturer of any other
Member, for any purposes other than U.S. federal and state tax purposes, and that this Agreement not be construed to suggest otherwise. No Member shall be liable for the debts, obligations or liabilities of the Company, including under a judgment
decree or order of a court. 
 SECTION 2 

MEMBERS AND UNITS 
 2.1
Authorized Units. The Company has authority to issue Common Units, Series A Preferred Units, Series B Preferred Units, Series B-1 Preferred Units and such other classes or series of Units as may be approved by the Board and each of the
Significant Securityholders in accordance with the terms of this Agreement. As of the Effective Date, the authorized LLC Capital Units are (a) (i) that number of Common Units equal to the number of shares of Common Stock, par value $0.001
per share, of Holdco (“Common Stock”) which are issued and outstanding as of the Effective Date, all of which Common Units are issued and outstanding and held by Holdco as the sole holder of Common Units as of the Effective Date,
plus (ii) such additional number of Common Units as may be issued in accordance with the terms of this Agreement and the Master Rights Agreement, including, without limitation, (A) upon the conversion of Series A Preferred Units, Series B
Preferred Units and/or Series B-1 Preferred Units pursuant to the terms hereof, (B) upon the issuance of Common Stock of Holdco pursuant to the Holdco Stock Plan as provided in Section 3.4(b), and (C) as contemplated by
Sections 4.2 and 9.1 of the Master Rights Agreement, minus (iii) such number of Common Units as may be purchased or repurchased from Holdco or otherwise retired in accordance with the terms of this Agreement and the Master
Rights Agreement, including, without limitation, (A) upon the repurchase or other retirement for any reason of Common Stock of Holdco by Holdco pursuant to the Holdco Stock Plan in accordance with Section 3.4(b), and (B) as
contemplated by Section 9.1(f) of the Master Rights Agreement, (b) 3,900,000 Series A Preferred Units, all of which are issued and outstanding and held by Holdco as the sole holder of Series A Preferred Units as of the Effective
Date, (c) 6,510,860 Series B Preferred Units, all of which are issued and outstanding and owned by the holders of Series B Preferred Units as reflected on Exhibit A 

  
 3 

 
hereto as of the Effective Date, and (d) 488,281 Series B-1 Preferred Units, of which 65,105 Units are issued and outstanding and held by Holdco as the sole holder of Series B-1 Preferred
Units as of the Effective Date. The number of Common Units, Series A Preferred Units, Series B Preferred Units and Series B-1 Preferred Units held by Holdco shall equal the number of shares of Common Stock, Series A Preferred Stock, Series B
Preferred Stock and Series B-1 Preferred Stock, respectively, of Holdco that are issued and outstanding in compliance with the terms of the Master Rights Agreement from time to time. In addition, if Holdco should issue any future class or series of
capital stock in compliance with the terms of the Master Rights Agreement with respect to which Corresponding Units (as defined in the Master Rights Agreement) are designated, then the number of such Corresponding Units outstanding and held by
Holdco shall equal the number of shares of such future class or series of capital stock of Holdco which are issued and outstanding in compliance with the terms of the Master Rights Agreement. All Units issued hereunder shall be uncertificated Units
unless otherwise determined by the Board. 
 2.2 Names, Addresses and Units of Members. The names, addresses and number and
type of Units of the Members are set forth on Exhibit A hereto. Subject to all provisions contained in this Agreement, the Board shall amend Exhibit A from time to time to reflect the admission or withdrawal of Members; the sale,
grant, issuance or redemption of Units; the receipt of Capital Contributions; or a change of a Member’s address. 
 2.3
Voting Rights. 
 (a) Generally. (i) Except as provided in any provision of this Agreement which may impose additional
requirements or the affirmative vote of a greater percentage of the number of Units of one or more series or classes of Units for the adoption or approval of any action by the Company, any event, transaction or occurrence requiring approval of the
Members shall be deemed to require a vote of the holders of a majority of the voting power of the then outstanding Units, voting together and not as a separate class, including in such majority at least two of the Significant Securityholders.
Irrespective of any provision of Section 18-209 of the Act, but subject to the terms of this Agreement, including, but not limited to Section 2(e) hereof, a merger or other Sale of the Company shall not require approval by any separate
class or group of Members. 
 (ii) Except as required by law, the Series B-1 Preferred Units shall be non-voting and the holders thereof
shall not be entitled to notice of meeting of Members or written consents in lieu thereof. 
 (b) Preferred Unit Voting Rights. Each
Voting Preferred Unit shall entitle the holder thereof to such number of votes per Unit, on each action with respect to which the holders of Voting Preferred Units are entitled to vote, as shall equal the number of Common Units into which such
Voting Preferred Unit is convertible on the record date for determination of the Members entitled to vote. Except as provided by the Act, the holders of Voting Preferred Units shall be entitled to vote, together with holders of Common Units, with
respect to any matter upon which holders of Common Units have the right to vote. 

  
 4 

 (c) Vote of Series A Preferred Members. Notwithstanding anything to the contrary in this
Agreement or the LLC Law, the Company shall not, by amendment, merger, consolidation or otherwise, take any action that alters or changes the rights, preferences or privileges of the Series A Preferred Units in a manner that is adverse to the Series
A Preferred Units, unless approved by the holders of at least 65% of the then-outstanding Series A Preferred Units. 
 (d) Vote of Series
B Preferred Members. Notwithstanding anything to the contrary in this Agreement or the LLC Law, the Company shall not, by amendment, merger, consolidation or otherwise, take any action that alters or changes the rights, preferences or privileges
of the Series B Preferred Units in a manner that is adverse to the Series B Preferred Units, unless approved by the holders of at least 75% of the then-outstanding Series B Preferred Units. 

(e) Protective Provisions. The Company shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any
of the following without (in addition to any other vote required by the LLC Law or this Agreement) the written consent or affirmative vote of the holders of at least 75% of the then outstanding Voting Preferred Units (including in such supermajority
each Member or stockholder of Holdco which at the time is a Significant Securityholder), given in writing or by vote at a meeting, and any such act or transaction entered into without such consent or vote shall he null and void ab initio, and of no
force or effect: 
 (i) amend or repeal any provision of this Agreement or other organizational documents of the Company; 

(ii) authorize or issue any class or series of Equity Security having any right, preference or priority superior to or on a parity with the
Series B Preferred Units; 
 (iii) except (A) with respect to the adjustments set forth in Section 2.1 and (B) in
connection with the issuance of one Common Unit to Holdco in respect of each share of Common Stock issued by Holdco pursuant to Holdco’s 2011 Equity Incentive Plan, up to a maximum number of such Common Units equal to 2,285,317 minus the number
of shares of Common Stock of Holdco outstanding as of the Effective Date (provided that (i) the foregoing maximum shall be increased to the extent that any shares of Common Stock of Holdco outstanding as of the Effective Date are repurchased by
Holdco and (ii) any such Units issued in respect of shares of Common Stock repurchased by Holdco shall not be counted toward such maximum number unless and until such shares are re-granted) in accordance with the terms of the Master Rights
Agreement; 
 (iv) redeem, retire, purchase or acquire, directly or indirectly, Units (other than with respect to the recovery of Common
Units from Holdco upon (A) the repurchase or forfeiture of Common Stock issued by Holdco under the Holdco Stock Plan or (B) as contemplated by Section 9.1(1) of the Master Rights Agreement); 

(v) materially change the Business; 

  
 5 

 (vi) grant any exclusive license to any of the Company’s or any of its subsidiaries’
material intellectual property rights; 
 (vii) incur or guarantee, or permit its subsidiaries to incur or guarantee, any indebtedness in
excess of $15,000,000; 
 (viii) liquidate, dissolve or wind up the Company, or cause the bankruptcy or voluntary insolvency of the Company;

 (ix) hire, terminate or change the compensation of any employee of the Company or any of its subsidiaries whose annual base salary is
equal to or greater than $180,000; 
 (x) pay or declare any Distributions or dividends (other than as provided in Sections 5.1 and
5.3); 
 (xi) unless approved by a majority of the Board, including in such majority at least one designee of each Significant
Securityholder, approve or amend the Company’s operating plan (the “Annual Budget”) for any fiscal year (it being understood that deviations from the Annual Budget as contemplated by subclause (xii) below shall not be
deemed amendments to the Annual Budget); 
 (xii) unless approved by a majority of the Board, including in such majority at least one
designee of each Significant Securityholder, make or permit its subsidiaries to make any expenditures or commitments (A) in excess of 5% of the total operating expenses reflected in the Annual Budget, or (B) in excess of 10% of the amount
reflected in any line item in the Annual Budget; 
 (xiii) sell assets of the Company or any of its subsidiaries in a single transaction or
series of related transactions having a fair market value in excess of $15,000,000, or make or permit its subsidiaries to make investments in or acquisitions of any Person, which investment or acquisition has a fair market value in excess of
$15,000,000; 
 (xiv) otherwise enter into or be a party to or permit any of its subsidiaries to enter into or be a party to any transaction
with any affiliate, director, officer, or employee of the Company or any “associate” (as defined in Rule 12b-2 promulgated under the Exchange Act) of any such Person, except for transactions with respect to which it is reasonably apparent
from the face of the agreement, taking into account the entire agreement, contemplated by agreements in effect as of the Original Issue Date (and as such agreements are in effect as of the Original Issue Date), and transactions in the ordinary
course of business and pursuant to reasonable requirements of the Business and upon fair and reasonable terms that are approved by a majority of the disinterested members of the Board after disclosure of the affiliate relationship; 

(xv) effect or make any subdivision, recapitalization or reorganization of the outstanding Units, or any split of or dividend or distribution
payable in, Units (collectively, a “Recapitalization”), except for a Recapitalization of any Corresponding Units (as defined in the Master Rights Agreement) that is concurrently effected or made in an identical

  
 6 

 
manner by Holdco with respect to its applicable outstanding Corresponding Shares (as defined in the Master Rights Agreement), in compliance with the Master Rights Agreement; 

(xvi) except as otherwise provided in this Agreement, make any significant tax elections; and 

(xvii) enter into any agreement or covenant that obligates the Company or any subsidiary to do any of the foregoing. 

2.4 Conversion of Preferred Units; Adjustments for Diluting Issuances. 

(a) Right to Convert. 

(i) Each Series A Preferred Unit shall be convertible, at the option of the holder thereof, at any time and from time to time, into such
number of fully paid and nonassessable Common Units as is determined by dividing the Original Series A Issue Price by the Series A Conversion Price (as defined below) in effect at the time of conversion. The conversion price of Series A Preferred
Units (the “Series A Conversion Price”) shall initially be $10.00 per Unit. The Series A Conversion Price, and the rate at which Series A Preferred Units may be converted into Common Units, shall be subject to adjustment as provided
below. 
 (ii) Each Series B Preferred Unit shall be convertible, at the option of the holder thereof, at any time and from time to time,
into such number of fully paid and nonassessable Common Units as is determined by dividing the Original Series B Issue Price by the Series B Conversion Price (as defined below) in effect at the time of conversion. The conversion price of Series B
Preferred Units (the “Series B Conversion Price” and, together with the Series A Conversion Price, the “Conversion Prices”) shall initially be $15.36 per Unit. The Series B Conversion Price, and the rate at which
Series B Preferred Units may be converted into Common Units, shall be subject to adjustment as provided below. 
 (iii) Each Series B-1
Preferred Unit shall be convertible, at the option of the holder thereof, at any time and from time to time, into such number of fully paid and nonassessable Common Units as is determined by dividing the Original Series B Issue Price by the Series B
Conversion Price in effect at the time of conversion. The Series B Conversion Price, and the rate at which Series B-1 Preferred Units may be converted into Common Units, shall be subject to adjustment as provided below. 

(b) Automatic Conversion. Each Preferred Unit then outstanding shall automatically be converted into such number of Common Units as is
determined by (i) for the Series A Preferred Units, dividing the Original Series A Issue Price by the then effective Series A Conversion Price, and (ii) for the Series B Preferred Units and Series B-1 Preferred Units, dividing the Original
Series B Issue Price by the then effective Series B Conversion Price, upon (A) the agreement of the holders of at least 75% of the then outstanding Preferred Units voting together as a single class (including in such supermajority each Member
or stockholder of Holdco that at the time is a Significant Securityholder) that all of the Preferred Units shall be converted into Common Units, or (B) the closing of the sale of Common Stock of Holdco (or a successor in interest to the
Company) in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, in which the gross cash 

  
 7 

 
proceeds to Holdco (before deduction of underwriting discount, commissions and expenses of sale) are at least $75,000,000.00 and the price per share paid by the public for such Common Stock of
Holdco is at least three times the Original Series B Issue Price (a “Qualified Public Offering”). 
 (c) Fractional
Units. No fractional Common Units shall be issued upon conversion of Preferred Units. In lieu of any fractional shares to which a holder would otherwise be entitled, the Company shall pay cash in an amount equal to the product (calculated to the
nearest cent) of such fraction and the fair market value of one Common Unit as determined in good faith by the Board. Whether or not fractional shares are issuable upon such conversion shall be determined on the basis of the total number of
Preferred Units the holder is then converting into Common Units and the number of Common Units issuable upon conversion of such Preferred Units. 

(d) Mechanics of Conversion. 

(i) In order for a holder of Preferred Units to voluntarily convert Preferred Units into Common Units, such holder shall surrender the
certificate or certificates representing such Preferred Units (if such Preferred Units are represented by a certificate or certificates), at the office of the transfer agent for the Preferred Units (or at the principal office of the Company if the
Company serves as its own transfer agent), together with written notice that such holder elects to convert all or any portion of the Preferred Units represented by such certificate or certificates. Such notice shall state such holder’s name or
the names of the nominees in which such holder wishes the certificate or certificates for Common Units to be issued (if such Common Units will be represented by a certificate or certificates). If required by the Company, certificates surrendered for
conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form reasonably satisfactory to the Company, duly executed by the registered holder or such holder’s attorney duly authorized in writing. The
date of receipt of such certificates (if such units are represented by certificates) and notice by the transfer agent (or by the Company if the Company serves as its own transfer agent) shall be the conversion date (the “Conversion
Date”). In addition, any conversion may be conditional upon the happening of a specific event, in which event the person(s) entitled to receive Common Units issuable upon such conversion of such Preferred Units shall not be deemed to have
converted such Preferred Units until immediately prior to the happening of such event. The Company shall, as soon as practicable after the Conversion Date, issue and deliver to the holder of such Preferred Units, or to such holder’s nominees, a
certificate or certificates representing the number of full Common Units to which such holder is entitled (unless such Common Units are uncertificated), together with cash in lieu of any fractional share. 

(ii) In the event of a conversion pursuant to Section 2.4(b), the outstanding Preferred Units shall be converted automatically
without any further action by the holders of such Preferred Units and whether or not the certificates representing such shares are surrendered to the Company or its transfer agent. The Company shall not be obligated to issue certificates
representing the Common Units issuable upon such automatic conversion unless and until the certificates, if any, representing such Preferred Units are either delivered to the Company or its transfer agent, or the holder notifies the Company or its
transfer agent that such certificate or certificates have been lost, stolen or destroyed and executes an agreement 

  
 8 

 
satisfactory to the Company to indemnify the Company from any loss incurred by it in connection with such certificates, including an indemnity bond in such amount as the Company reasonably deems
appropriate in its discretion. Such automatic conversion shall be deemed to have been made immediately prior to the effective date of the applicable vote or written consent or the closing of the Qualified Public Offering, as the case may be, and the
person or persons entitled to receive the Common Units issuable upon such conversion shall be treated for all purposes as the record holder or holders of such Common Units on such date which date shall be the Conversion Date. Immediately upon such
automatic conversion, all Preferred Units shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease and terminate, except only the right of the holders thereof, upon surrender of their certificate
or certificates therefor (if such units are represented by a certificate or certificates), to receive certificates representing the number of Common Units into which such Preferred Units has been converted, including certificates therefor if the
Common Units are to be represented by certificates (and cash, if any, with respect to any fractional share as provided in Section 2.4(c)). If so required by the Company, certificates surrendered for conversion shall be endorsed or
accompanied by written instrument or instruments of transfer, in form reasonably satisfactory to the Company, duly executed by the registered holder or such holder’s attorney duly authorized in writing. 

(e) Adjustments to Conversion Price for Diluting Issuances. 

(i) Special Definitions. For purposes of this Section 2.4(e), the following definitions shall apply: 

(A) “Option” shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Units or Convertible
Securities. 
 (B) “Original Issue Date” shall mean the date on which the first Series B Preferred Unit is issued. 

(C) “Convertible Securities” shall mean any evidence of indebtedness, shares or other securities directly or indirectly convertible
into, or exercisable or exchangeable for, Common Units. 
 (D) “Additional Common Units” shall mean all Common Units issued (or,
pursuant to Section 2.4(e)(iii) below, deemed to be issued) by the Company after the Original Issue Date, other than Common Units issued (or pursuant to Section 2.4(e)(iii) below, deemed to be issued) by the Company, as applicable, or
issuable for or in connection with the following (collectively, the “Exempt Securities”): 
 (I) upon the conversion of Preferred
Units or as a dividend or other distribution on Preferred Units; 
 (II) issuances of Common Units, pursuant to an acquisition approved by
the Board, of a corporation or other business entity by merger, consolidation, purchase of substantially all of the assets or equity securities or other reorganization; 

  
 9 

 (III) issuances of Common Units to Holdco in respect of shares of Common Stock of Holdco issued
or deemed issued to directors or employees of, or consultants to, Holdco in a manner determined by the Holdco Board, including, without limitation, pursuant to any stock option or equity incentive plan of Holdco, in each case, subject to the
obligations of the Master Rights Agreement; 
 (IV) issuances of Common Units pursuant to a Qualified Public Offering; 

(V) issuances of Common Units in connection with arm’s length equipment lease financing arrangements or bank financing transactions
approved by the Board provided that Additional Common Units are not the sole component of any such financing; 
 (VI) issuances of Common
Units in connection with arm’s length transactions involving research or development funding, technology licensing or joint marketing or manufacturing arrangements approved by the Board provided that such issuance is primarily for purposes
other than equity financing; 
 (VII) upon the conversion, exercise or exchange of Options and Convertible Securities outstanding on the
Original Issue Date; 
 (VIII) in a transaction which results in an adjustment pursuant to Section 2.4(f) or Section
2.4(g); 
 (IX) upon the conversion, exercise or exchange of any securities of the Company into securities of Holdco pursuant to
Section 12.3 of the Master Rights Agreement; or 
 (X) issuance of Common Units or Preferred Units to Holdco upon the issuance of
securities of Holdco pursuant to and in compliance with Section 4.2 of the Master Rights Agreement. 
 (ii) No Adjustment of
Conversion Price. No adjustment in the number of Common Units into which a Preferred Unit is convertible shall be made, by adjustment in the applicable Conversion Price thereof unless the consideration per share (determined pursuant to
Section 2.4(e)(v) below) for an Additional Common Unit issued or deemed to be issued by the Company is less than the Conversion Price in effect on the date of, and immediately prior to, the issuance of such Additional Common Unit. 

(iii) Issuance of Securities Deemed Issuance of Additional Shares of Common Equivalents. If the Company at any time, or from time to
time, after the Original Issue Date shall issue any Options or Convertible Securities (excluding Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of
securities entitled to receive any such Options or Convertible Securities, then the maximum number of Common Units (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or
exchangeability but without regard to automatic adjustments to such number 

  
 10 

 
pursuant to a broad-based weighted average or other similar anti-dilution provision of such Option or Convertible Security) issuable upon the exercise of such Options or, in the case of
Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Common Units issued as of the time of such issue or, in case such a record date shall have been fixed, as of the
close of business on such record date, provided that in any such case in which Additional Common Units are deemed to be issued: 
 (A) no
further adjustment in the Conversion Price shall be made upon the subsequent issuance of Convertible Securities or Common Units upon the exercise of such Options or conversion or exchange of such Convertible Securities; 

(B) if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any increase in the
consideration payable to the Company, or decrease in the number of Common Units issuable upon the exercise, conversion or exchange thereof, the Conversion Price computed upon the original issuance thereof, and any subsequent adjustment based
thereon, shall, upon any such increase or decrease becoming effective, be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities; 

(C) upon the expiration of any such Options or any rights of conversion or exchange under such Convertible Securities which shall not have
been exercised, the Conversion Price computed upon the original issuance thereof, and any subsequent adjustments based thereon, shall, upon such expiration, be recomputed as if, 

(I) in the case of Convertible Securities or Options for Common Units, the only Additional Common Units issued were the Common Units, if any,
that were actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities and the consideration received therefor was the consideration actually received by the Company for the issuance of all such
Options, whether or not exercised, plus the consideration actually received by the Company upon such exercise, or for the issuance of all such Convertible Securities which were actually converted or exchanged, plus the additional consideration, if
any, actually received by the Company upon such conversion or exchange, and 
 (II) in the case of Options for Convertible Securities, only
the Convertible Securities, if any, that were actually issued upon the exercise thereof were issued at the time of issuance of such Options, and the consideration received by the Company for the Additional Common Units deemed to have been then
issued was the consideration actually received by the Company for the issuance of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Company upon the issuance of the Convertible Securities with
respect to which such Options were actually exercised; 
 (D) no readjustment pursuant to clause (C) above shall have the effect of
increasing the Conversion Price to an amount which exceeds the lower of (i) the Conversion Price on the original adjustment date, or (ii) the Conversion Price that would have resulted from any issuance of Additional Common Units between
the original adjustment date and such readjustment date; and 

  
 11 

 (E) in the case of any Options which expire by their terms not more than 90 days after the date
of issuance thereof or in the case of any Option or Convertible Securities with respect to which the maximum number of Common Units issuable upon exercise or conversion or exchange thereof is not determinable, any adjustment to the Conversion Price
that would result under the terms of this Section 2.4(e) shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of
calculating such adjustment to the Conversion Price that such issuance took place at the time such calculation can first be made. 
 (iv)
Adjustment of Conversion Price Upon Issuance of Additional Shares of Common Equivalents. Subject to the provisions of Section 2.4(e)(ii) above, in the event the Company shall at any time after the Original Issue Date issue
Additional Common Units (including Additional Common Units deemed to be issued pursuant to Section 2.4(e)(iii)), without consideration or for a consideration per share less than the Conversion Price in effect for any series of Preferred
Units on the date of and immediately prior to such issuance, then and in such event such Conversion Price of the applicable series of Preferred Units shall be reduced, concurrently with such issuance to a price (calculated to the nearest cent)
determined by multiplying such Conversion Price by a fraction, (x) the numerator of which shall be the number of Common Units outstanding immediately prior to such issuance plus the number of Common Units which the aggregate consideration
received by the Company for the total number of Additional Common Units so issued would purchase at the applicable Conversion Price, and (y) the denominator of which shall be the number of Common Units outstanding immediately prior to such
issuance plus the number of such Additional Common Units so issued; provided that for the purposes of this Section 2.4(e)(iv), all Common Units (but, for the avoidance of doubt, not Common Stock of Holdco) issuable upon exercise,
conversion or exchange of Options or Convertible Securities and all Common Units reserved for issuance upon issuance of shares of Common Stock of Holdco reserved for issuance but not yet issued pursuant to Holdco’s stock option plans, as the
case may be, shall be deemed to be outstanding as though they were Common Units, and immediately after any Additional Common Units shall be deemed issued pursuant to Section 2.4(e)(iii) above, such Additional Common Units shall be deemed
to be outstanding. Notwithstanding the foregoing, the applicable Conversion Price shall not be so reduced at such time if the amount of such reduction would be an amount less than $.01, but any such amount shall be carried forward and reduction with
respect thereto made at the time of and together with any subsequent reduction which, together with such amount and any other amount or amounts so carried forward, shall aggregate $.01 or more. 

(v) Determination of Consideration. For purposes of this Section 2.4(e), the consideration received by the Company for the
issuance of any Additional Common Units shall be computed as follows: 
 (A) Cash and Property. Such consideration shall: 

(I) insofar as it consists of cash, be the amount of cash received by the Company; 

  
 12 

 (II) insofar as it consists of property other than cash, be the fair market value thereof at the
time of such issuance, as determined in good faith by the Board; and 
 (III) in the event Additional Common Units are issued together with
other shares or securities or other assets of the Company, for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (I) and (II) above, as determined in good faith by the Board.

 (B) Options and Convertible Securities. The consideration per share received by the Company for Additional Common Units deemed to
have been issued pursuant to Section 2.4(e)(iii) above, relating to Options and Convertible Securities, shall be determined by dividing: 

(x) the total amount, if any, received or receivable by the Company as consideration for the issuance of such Options or
Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible
Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by 

(y) the maximum number of Common Units (as set forth in the instruments relating thereto) issuable upon the exercise of such
Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities. 

(f) Adjustment for Unit Splits and Combinations. If the Company shall at any time, or from time to time, after the Original Issue Date
effect a subdivision of the outstanding Common Units, the Conversion Price then in effect immediately before that subdivision shall be proportionately decreased. If the Company shall at any time, or from time to time, after the Original Issue Date
combine the outstanding Common Units, the Conversion Price then in effect immediately before the combination shall be proportionately increased unless the outstanding Preferred Units are combined in a proportionate manner (in which event no
adjustment shall take place pursuant to this subparagraph (f) and the Original Issuance Price and the Conversion Price shall be adjusted proportionately). Any adjustment under this subsection shall become effective concurrently with the
effectiveness of such subdivision or combination. 
 (g) Adjustment for Unit Dividends and Distributions. If the Company at any time,
or from time to time, after the Original Issue Date shall make or issue a dividend or other Distribution payable in additional Common Units, then and in each such event the Conversion Price then in effect shall be decreased concurrently with the
issuance of such dividend or Distribution, by multiplying the Conversion Price then in effect by a fraction: (x) the 

  
 13 

 
numerator of which shall be the total number of Common Units issued and outstanding immediately prior to the time of such issuance, and (y) the denominator of which shall be the total number
of Common Units issued and outstanding immediately prior to the time of such issuance plus the number of Common Units issuable in payment of such dividend or Distribution. 

(h) Adjustment for Recapitalization, Reclassification, Exchange or Substitution. If the Common Units issuable upon the conversion of
Preferred Units shall be changed into the same or a different number of shares of any class or classes of stock, whether by recapitalization, reclassification, exchange, substitution or other similar event (other than pursuant to subsections
(f) or (g) or a Sale of the Company), each holder of Preferred Units shall thereafter receive upon conversion of such Preferred Units, in lieu of the number of Common Units which such holder would otherwise have been entitled to receive,
the number of shares of such other class or classes of equity securities which a holder of the number of Common Units deliverable upon conversion of the Preferred Units held by such holder of Preferred Units would have been entitled to receive upon
such recapitalization, reclassification, exchange, substitution or other similar event. 
 (i) Automatic Common Unit Splits and
Combinations. If Holdco shall at any time, or from time to time, effect a subdivision of its outstanding Common Stock, then the Company shall effect a subdivision of its Common Units in the same proportion. If Holdco shall at any time, or from
time to time, effect a combination of its outstanding Common Stock, then the Company shall effect a combination of its Common Units in the same proportion. Any subdivision or combination under this subsection shall become effective concurrently with
the subdivision or combination effected by Holdco. 
 (j) Certificate as to Adjustments. Upon the occurrence of each adjustment of the
Conversion Price pursuant to this Section 2.4, the Company at its expense shall promptly compute such adjustment in accordance with the terms hereof and furnish to each holder of Preferred Units a certificate setting forth such
adjustment and showing in reasonable detail the facts upon which such adjustment is based. The Company shall, upon the written request at any time of any holder of Preferred Units, furnish or cause to be furnished to such holder a similar
certificate setting forth (i) such adjustments, (ii) the Conversion Price then in effect, and (iii) the number of Common Units which would then be received upon the conversion of the Preferred Units. 

(k) Notices. All notices hereunder shall be in writing and shall be deemed effectively given: (i) upon personal delivery to the
person to be notified; (ii) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day; (iii) five days after having been sent by registered or certified mail,
return receipt requested, postage prepaid; or (iv) the next business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the
holder at its address and/or facsimile number appearing on the books of the Company. 

  
 14 

 SECTION 3 

CAPITAL CONTRIBUTIONS 

3.1 Capital Contributions. Each Member has made, or shall be deemed to have made, the Capital Contributions as set forth on
Exhibit A to this Agreement. No Member will be required to make any Capital Contributions other than the Capital Contributions that Members are required to make pursuant to this Section 3.1. The Units of the Company held by the
Members of the Company are as set forth opposite such Member’s name on Exhibit A to this Agreement. 
 3.2 Other
Matters. 
 (a) Return of Capital. Except as otherwise provided in this Agreement, no Member may demand or receive a return of its
Capital Contribution or withdraw from the Company. Under circumstances requiring a return of any Capital Contribution, no Member will have the right to receive property other than cash, except as may be specifically provided in this Agreement. 

(b) Interest on Capital Contribution. Except as otherwise provided in this Agreement, no Member will receive any interest payment,
salary or draw with respect to its Capital Contribution or Capital Account or otherwise solely in its capacity as a Member. 
 (c) No
Personal Liability. No Member, in its capacity as a member, will be liable for the debts, liabilities, contracts or any other obligations of the Company. In addition, no Member shall be obligated to make an additional Capital Contribution to the
Company, whether to restore a negative Capital Account balance or otherwise. 
 3.3 Member Loans. Upon the approval of the
Board, any Member or Members, subject to any restrictions in this Agreement, may loan additional funds to the Company (each a “Member Loan”). Member Loans shall not be considered Capital Contributions and if any Member shall make a
Member Loan, the making of such loan shall not result in any increase in the amount of the Capital Account of such Member. The amount of any Member Loan shall be a debt of the Company to the Member making such Member Loan and shall be payable or
collectible in accordance with such commercially reasonable terms and conditions as agreed to by the Member making the Member Loan and the Company; provided, however, that such terms and conditions are no more favorable to such lending
Member than those that would be agreed to in an orderly transaction with a willing, unaffiliated lender in an arm’s-length transaction. 

3.4 Issuance of Additional Equity Securities. 

(a) Subject to compliance with Section 2.3, and except as otherwise expressly provided in this Agreement, the Board shall have the
right to cause the Company to issue additional Equity Securities (including creating other classes or series thereof having different rights); provided, however, that at any time following the date hereof, the Company shall not issue
Equity Securities to any Person unless such Person shall have executed a counterpart to this Agreement. 

  
 15 

 (b) Any time that Holdco issues a share of its Common Stock under its 2011 Equity Incentive Plan
or any subsequent stock or equity incentive plan for employees of or consultants to the Company or Holdco (collectively, the “Holdco Stock Plan”) in compliance with the terms of the Master Rights Agreement (including
Section 5.6(b) thereof), including pursuant to the exercise of an option granted in compliance with the terms of the Master Rights Agreement under the Holdco Stock Plan (or issues its Common Stock pursuant to the exercise of a warrant issued in
compliance with the terms of the Master Rights Agreement), the following shall occur: (i) the holder of the option, warrant or other right shall deliver the applicable purchase price to Holdco, (ii) Holdco shall deliver the purchase price
to the Company in exchange for the number of Common Units equal to the number of shares of Common Stock to be issued under the Holdco Stock Plan, and (iii) Holdco shall deliver to the holder the shares of Common Stock. To the extent the
ultimate recipient under the Holdco Stock Plan forfeits shares of Common Stock under the Holdco Stock Plan, upon cancellation of such shares, the number of Common Units held by Holdco shall be reduced by an equal amount. Holdco shall make an
election under Section 83(b) of the Code (an “83(b) Election”) with respect to any Common Units it is issued under clause (iv) above if an 83(b) Election was made with respect to the related shares of Common Stock. 

3.5 Holdco Contributions. Holdco shall contribute to the Company any cash that it receives from the Company pursuant to
Section 5.2(c) to the extent such cash is not spent by Holdco to pay the expenses described in Section 5.2(c). 

SECTION 4 
 CAPITAL
ACCOUNTS AND ALLOCATIONS 
 4.1 Capital Accounts. The creation and maintenance of Capital Accounts is described on
Exhibit C to this Agreement. It is the intent of the Company to maintain a separate capital account (each a “Capital Account”) for each Member in accordance with the rules of Treasury Regulations
Section 1.704-1(b)(2)(iv). In addition, for purposes of proper allocation of Profits and Losses pursuant to Section 4.2, Exhibit C and distributions pursuant to Section 5, it is the intent of the Company to maintain a separate
capital account for each Common Member, Series A Preferred Member, Series B Preferred Member and Series B-1 Preferred Member, even if a Member is both a Common Member, a Series A Preferred Member and/or a Series B Preferred Member and/or a Series
B-1 Preferred Member, as if the Member was a separate Member with respect to each class or series of Units owned by the Member. As such, this Section 4.1 and Exhibit C to this Agreement shall be interpreted and applied in a manner
consistent therewith. 
 4.2 Allocation of Profits and Losses. Except as otherwise provided in this Agreement, Profits
and Losses for each year (or portion thereof for which allocations are being made) shall be allocated among the Members in a manner such that the Capital Account balance of each such Member for each class or series of Units held by the Member,
immediately after making such allocation and after taking into account amounts specially allocated pursuant to this Section 4.1, is as nearly as possible (limited to the amounts of Profit and Losses available for allocation), on a
proportionate basis equal to (a) the Distributions that would be made to such Member with respect to each class or series of Units held by the Member pursuant to Section 5 if 

  
 16 

 
the Company were dissolved, its affairs wound up and its assets sold for cash equal to their Book Value, all Company liabilities were satisfied (limited with respect to each non-recourse
liability to the Book Value of the assets securing such liability), and the net assets of the Company were distributed in accordance with Section 5 to the Members immediately after making such allocation, minus (b) such
Member’s share of the Company’s Minimum Gain and such Member’s Member Nonrecourse Debt Minimum Gain. For the avoidance of doubt, items of income, gain, loss or deduction of the Company recognized for federal income tax purposes shall
be allocated among the Members in the same manner as the Profits or Losses of which such items are components are allocated pursuant to the preceding sentence. The Members agree that any Preferred Return is intended to reflect a right to an
allocable share of Profits and not an allocation of gross income or a guaranteed payment within the meaning of Section 707(a) or (c) of the Code. Notwithstanding the foregoing, following a Liquidation Event or a Sale of the Company, or any
distribution of cash, securities or other assets pursuant to a Sale of the Company, the Company shall, to the extent necessary, allocate individual items of income, gain, loss or deduction of the Company among the Members such that the Capital
Account balance of each Member, with respect to each class or series of Units held by such Member, is as nearly as possible, on a proportionate basis, equal to (i) the Distributions that would be made to such Member pursuant to Section 5.3
if the Company were dissolved, its affairs wound up and its assets sold for cash equal to their Book Value, all Company liabilities were satisfied (limited with respect to each non-recourse liability to the Book Value of the assets securing such
liability), and the net assets of the Company were distributed in accordance with Section 5.3 to the Members immediately after making such allocation, minus (ii) such Member’s share of the Company’s Minimum Gain and such
Member’s Member Nonrecourse Debt Minimum Gain. 
 SECTION 5 

DISTRIBUTIONS; TAX MATTERS 

5.1 Tax Distributions. Subject to Section 5.4, within 10 days prior to the date on which the Members’ quarterly
estimated tax payments are due (i.e., each April 5, June 5, September 5 and January 5), the Company shall calculate and distribute to each Member such Member’s Mandatory Tax Distribution Amount (as defined
below). The “Mandatory Tax Distribution Amount” for each Member in each fiscal quarter of each fiscal year means an amount in cash equal to the excess of (a) the product of (i) the net taxable income of the Company
allocated to (or reasonably estimated to be allocable to) such Member from the beginning of the fiscal year through the end of the most recent month attributable to the items allocated to such Member under Section 4.2(a) and Exhibit
C of this Agreement and (ii) the maximum combined federal and state income tax rates applicable to income of an individual resident in California (taking into account the character of such income and the deductibility of state taxes for
federal income tax purposes), plus the rate reflecting the net investment income tax pursuant to Section 1411 of the Code, for such fiscal year, less (b) the aggregate Mandatory Tax Distribution Amounts distributed to such Member for all
prior months in such fiscal year. Solely for purposes of this Section 5.1, if a Member is allocated a net loss for federal income tax purposes under Section 4.2 and Exhibit C of this Agreement for any fiscal year or
period of the Company beginning after the date of this Agreement, such net loss shall be offset against, and shall reduce the net income allocated (or reasonably estimated to be allocable) to such Member under Section 4.2 and Exhibit
C of this Agreement in subsequent fiscal quarters of the Company 

  
 17 

 
(until such net loss is exhausted) for purpose of calculating the Mandatory Tax Distribution Amount for such Member for such subsequent fiscal quarters within the same calendar year If available
cash, as determined by the Board, is insufficient to pay all of the Mandatory Tax Distribution Amounts due hereunder, then each Member’s share thereof shall be reduced by a pro rata amount based on the ratio of such Member’s Mandatory Tax
Distribution Amount to all Members’ Mandatory Tax Distribution Amounts. All distributions to each Member of its Mandatory Tax Distribution Amount shall be treated as an advance against distributions payable under any other section of this
Agreement to such Member (other than Section 5.2(c)) (each, a “Tax Distribution Advance”), and taken into account in determining the amount of such other distributions (it being understood that such adjustments are
provided herein in Section 5.2(d) and the definitions herein of Adjusted Series A Liquidation Preference, Adjusted Series B Liquidation Preference and Adjusted Series B-1 Liquidation Preference). If, as a result of any tax audit or other
procedure binding on the Members, there is a later change in the amount of taxable income allocated to any Member or Members for any fiscal year or other period from what was originally reported to such Member (or any Member is required to report
the Preferred Return as a guaranteed payment), the Company shall thereafter make distributions to Members (which shall be treated as Mandatory Tax Distribution Amounts) to each Member in the amounts necessary, taking into account prior
distributions, for each Member to receive aggregate distributions, under this Section 5.1, reflecting the Mandatory Tax Distribution Amount each such Member should receive reflecting such changes in the reporting of taxable income.
Notwithstanding anything to the contrary contained in this Agreement, after taking into account distributions effected pursuant to this Section 5.1, if any, subsequent distributions with respect to each Unit pursuant to Sections 5.2,
5.3 and 9.2 shall be adjusted as necessary to ensure that, over the period of time since the date of this Agreement, the aggregate cash or other property distributed with respect to such Unit under this Agreement shall be equal to the
aggregate amount which would have been distributed with respect to such Unit had there been no distributions pursuant to this Section 5.1 and had this Section 5.1 not been part of this Agreement. 

5.2 Distributions. 
 (a)
Generally. Except as provided in Sections 5.1, 5.2(c) or 5.3, the Company shall not declare or make any other Distributions unless such Distribution is declared by the Board, subject to Section 2.3(e). 

(b) Distribution of Preferred Return. Except as set forth in Section 5.2(d) or in Section 5.3 hereof, the Series
A Preferred Return, the Series B Preferred Return or Series B-1 Preferred Return shall be payable only when, as, and if declared by the Board, and the Company shall be under no obligation to pay such Series A Preferred Return, Series B Preferred
Return or Series B-1 Preferred Return. 
 (c) Holdco Expense Distributions. To the extent necessary, the Company shall make special
distributions to Holdco in an amount equal to accounting, legal and administrative expenses (including franchise taxes) reasonably incurred by Holdco in the consummation of the transactions contemplated by the Purchase Agreements or in the
performance of Holdco’s obligations under this Agreement or the Master Rights Agreement, and in the monitoring or disposition of its investment in the Units, in each case when payments for 

  
 18 

 
such expenses are due. No such special distributions shall be treated as an advance against distributions payable under any other section of this Agreement. 

(d) Other Distributions. Subject to Section 5.3, any Distribution to the Members pursuant to this Section 5.2, other
than distributions made pursuant to Section 5.2(c), shall be made, after accounting for any Tax Distribution Advances, (i) first to the holders of Series B Preferred Units, until such holders have received an aggregate amount equal
to the Series B Preferred Return, then (ii) to the holders of Series A Preferred Units, until such holders have received an aggregate amount equal to the Series A Preferred Return, then (iii) to the holders of Series B Preferred Units,
until such holders have received an aggregate amount equal to the Series B Liquidation Preference Amount, then (iv) to the holders of Series A Preferred Units, until such holders have received an aggregate amount equal to the Series A
Liquidation Preference Amount, then (v) to the holders of Series B-1 Preferred Units until such holders have received and aggregate amount equal to the Series B-1 Preferred Return, then (vi) to the holders of Series B-1 Preferred Units,
until such holders have received an aggregate amount equal to the Series B-1 Liquidation Preference Amount, then (vii) to the holders of Common Units, until such holders have received an aggregate amount equal to the Series A Liquidation
Preference Amount, then (viii) to the holders of Series A Preferred Units and Common Units, pro rata based upon the number of Units held thereby (with respect to the Series A Preferred Units, on an as-converted to Common Units basis), until
such holders have received, with respect to each such unit, an aggregate amount under this clause (viii) together with all amounts distributed under the preceding clauses (i) through (vii) equal to the Series B Liquidation Preference
Amount, and then (ix) to the holders of Preferred Units and Common Units pro rata based upon the number of Units held thereby (with respect to the Preferred Units, on an as-converted to Common Units basis). 

5.3 Liquidation or Sale of the Company Distributions. Notwithstanding the provisions of Sections 5.1 and 5.2, with
respect to any Distribution following a Liquidation Event or a Sale of the Company, or any distribution of cash, securities or other assets pursuant to a Sale of the Company such Distribution or distribution shall be made as follows: 

(a) First, to the holders of Series B Preferred Units, pro rata in proportion to the number of Series B Preferred Units held by such holders,
until the holders of such Series B Preferred Units receive in respect of each Series B Preferred Unit held by them, the Adjusted Series B Liquidation Preference Amount; provided, however, that if the amount distributable pursuant to
Section 5.3(d) with respect to such Series B Preferred Units upon conversion into Common Units as a whole would be greater than the amount distributable pursuant to this Section 5.3(a), then such Series B Preferred Units
shall be treated for purposes of this Section 5.3 with respect to the applicable Distribution to have been converted into Common Units and the holders thereof shall be entitled to receive the amount distributable pursuant to
Section 5.3(d) in lieu of any amounts distributable pursuant to this Section 5.3(a) with respect to the Series B Preferred Units; 

(b) Second, to the holders of Series A Preferred Units, pro rata in proportion to the number of Series A Preferred Units held by such holders,
until the holders of such Series A Preferred Units receive in respect of each Series A Preferred Unit held by them, the Adjusted Series A Liquidation Preference Amount; provided, however, that if the amount distributable

  
 19 

 
pursuant to Section 5.3(d) with respect to such Series A Preferred Units upon conversion into Common Units as a whole would be greater than the amount distributable pursuant to this
Section 5.3(b), then such Series A Preferred Units shall be treated for purposes of this Section 5.3 with respect to the applicable Distribution to have been converted into Common Units and the holders thereof shall be
entitled to receive the amount distributable pursuant to Section 5.3(d) in lieu of any amounts distributable pursuant to this Section 5.3(b) with respect to the Series A Preferred Units; and 

(c) Third, to the holders of Series B-1 Preferred Units, pro rata in proportion to the number of Series B-1 Preferred Units held by such
holders, until the holders of such Series B-1 Preferred Units receive in respect of each Series B-1 Preferred Unit held by them, the Adjusted Series B-1 Liquidation Preference Amount; provided, however, that if the amount distributable
pursuant to Section 5.3(d) with respect to such Series B-1 Preferred Units upon conversion into Common Units as a whole would be greater than the amount distributable pursuant to this Section 5.3(c), then such Series B-1
Preferred Units shall be treated for purposes of this Section 5.3 with respect to the applicable Distribution to have been converted into Common Units and the holders thereof shall be entitled to receive the amount distributable pursuant
to Section 5.3(d) in lieu of any amounts distributable pursuant to this Section 5.3(c) with respect to the Series B-1 Preferred Units; and 

(d) Fourth, to the holders of Common Units, pro rata in proportion to the number of Common Units held by such holders, the Surplus Amount. 

If any of the assets of this Company are to be distributed under this Section 5.3 in a foam other than cash, then the fair
market value of the assets to be distributed to the Members shall be determined by an independent appraisal, performed by an independent third party appraiser mutually agreeable to the holders of at least 75% of the outstanding Voting Preferred
Units and the Board. 
 (e) In the event of a Sale of the Company, if any portion of the consideration payable to the Company or to
the Members of the Company is placed into escrow and/or is payable to the Company or the Members of the Company subject to contingencies (“Contingent Consideration”), then (i) the portion of such consideration that is not
placed in escrow and not subject to any contingencies (the “Initial Consideration”) shall be allocated among the Unitholders in accordance with Sections 5.3(a), (b), (c) and (d) as if the Initial
Consideration were the only consideration payable in connection with such Sale of the Company, and (ii) any Contingent Consideration which becomes payable to the Members of the Company upon release from escrow or satisfaction of contingencies
shall be allocated among the Unitholders in accordance with Sections 5.3(a), (b), (c) and (d) after taking into account payment of the Initial Consideration as part of the same transaction, and recalculating
whether any conversion of any series of Preferred Units to Common Units, as provided in Section 2.4 would have been economically rational based upon the aggregate amount of the Initial Consideration plus all Contingent Consideration
which becomes payable to the Unitholders upon release from escrow or satisfaction of contingencies; provided, however, in no event shall any recalculation be effected with- respect to any units of
Preferred Units which have been converted into Common Units (or received consideration in the Sale of the Company on an as-converted basis). 

  
 20 

 5.4 Preparation of Tax Returns; Tax Information. 

(a) Schedule K-1s. The Company shall arrange for the preparation and timely filing of all returns required to be filed by the Company
and shall provide Schedule K-1s (and any state or local equivalents) for each year to each Member by February 15th of the following year, unless otherwise extended by the Board. In the event of such
extension, the Company shall use reasonable best efforts to provide each Member with an estimate of the net taxable income of the Company allocated to (or reasonably estimated to be allocated to) such Member under Section 4 for a fiscal
year, together with an estimate of the state apportionment of such income, by February 15th of the following year. In addition, the Company shall provide a Member with such other tax information as the Member may reasonably request from time to
time as it relates to the Member’s interest in the Company. 
 (b) Estimated Payments. At least two weeks prior to the date in
which each Member’s quarterly estimated tax payments are due, the Company shall use reasonable best efforts to provide each Member with an estimate of the net taxable income of the Company reasonably estimated to be allocated to such Member
from the beginning of the fiscal year through the end of the most recent month attributable to the items allocated to such Member under Section 4. 

5.5 Tax Matters Member; Tax Elections. 

(a) Identity. Holdco is hereby designated the Tax Matters Member. 

(b) Authority. The Tax Matters Member is authorized and required to represent the Company (at the Company’s expense) in connection
with all examinations of the Company’s affairs by tax authorities, including resulting administrative and judicial proceedings, and to expend the Company’s funds for professional services reasonably incurred in connection therewith. Each
Member agrees to cooperate with the Company and to do or refrain from doing any or all things reasonably requested by the Company with respect to the conduct of such proceedings. The Tax Matters Member shall keep all Members reasonably informed of
the progress of any examinations, audits or other proceedings, and all Members shall have the right to participate in any such examinations, audits or other proceedings. 

(c) Elections. Notwithstanding anything to the contrary in this Agreement: 

(i) The taxable year shall be as set forth in Section 7.2, unless the Board shall determine otherwise in compliance with this
Agreement and applicable laws. 
 (ii) At the request of any Member which is a Significant Securityholder, the Company shall make an
election under Section 754 of the Code effective for the tax year requested by such Member. 
 (iii) Section C1(d) of
Exhibit C shall govern the election of the method to make allocations related to any property to which Section 704(c) of the Code applies. 

  
 21 

 (iv) The Tax Matters Member shall not, unless consented to by the Board, grant any extension to
or waive any statute of limitations period or otherwise extend the period for which any tax may be assessed or collected. 
 SECTION 6

 MANAGEMENT AND CONTROL 

6.1 Management by the Board. Except for situations in which the approval of the Members, or any portion thereof, is required by
this Agreement or by provisions of applicable LLC Law, the powers of the Company shall be exercised by or under the authority of, and the business and affairs of the Company shall be managed under the direction of the Board. Unless otherwise
provided for in this Agreement, the Board may, by the affirmative vote of a majority of the Board, make all decisions and authorize any and all actions for or on behalf of the Company not otherwise reserved to all or any portion of the Members. Each
Director shall be entitled to have one vote on any matter presented to the Board. No Director or Member acting in his or her individual capacity shall have the right, power or authority to act on behalf of or bind the Company, except (i) that a
Director or Member who is also an Officer of the Company may act on behalf of or bind the Company in his or her capacity as an Officer of the Company to the extent that he or she is authorized to do so or (ii) to the extent a Director is so
authorized by the Board. 
 6.2 Board Composition and Administration. 

(a) Composition. The size and composition of the Board shall be as set forth in Section 6 of the Master Rights Agreement, as the
same may be amended from time to time. 
 (b) Administration. Each Director shall be subject to removal and replacement as set forth
in Section 6 of the Master Rights Agreement, as the same may be amended from time to time, and such section shall also govern the power to appoint a Director to fill any vacancy created by the death, resignation or removal of any Director. A
Director need not be a resident of the State of Delaware. 
 6.3 Meetings of the Board. Meetings of the Board shall be held on a date
and at such time as the Board may determine for the purposes of transacting such business as may come before the meeting. Unless otherwise determined by the vote of a majority of the Directors then in office, the Board shall meet at least four
(4) times per year in accordance with an agreed-upon schedule. Additional meetings of the Board may be called by or at the request of any Director. The person or persons calling the meeting may fix any place, either within or without the State
of Delaware, as the place for holding any meeting of the Board called by them. Unless otherwise restricted by the Certificate or the LLC Law, as either may be amended from time to time, Board members may participate in a meeting by means of
conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation shall constitute presence in person at such meeting. Subject to any other restrictions
contained in this Agreement, no action shall be taken at any meeting of the Board unless the Directors representing a majority of the votes entitled to be cast by all members of the Board are present. Except as otherwise required by the LLC Law or
as otherwise provided 

  
 22 

 
in this Agreement, at any meeting of the Board at which a majority of the votes entitled to be cast by all members of the Board are present, Directors possessing a majority of the votes entitled
to be cast by all members of the Board may take action on behalf of the Board. A Director shall not be represented in proxy at any meeting of the Board or with respect to any matter requiring the vote of the Board. 

6.4 Notice of Board Meetings. Unless otherwise restricted by the Certificate or the LLC Law, written notice of any meeting of
the Board stating the place, date and time of the meeting and, in the case of a special meeting, the purpose thereof shall be given to each Board member not less than forty-eight (48) hours nor more than sixty (60) days before the meeting
date. Notice of any meeting of the Board may be given in person or by telephone, or sent by overnight courier, electronic transmission, facsimile or telegram to each Board member’s primary business or home and shall be deemed effectively given
(a) when sent if sent by electronic transmission, facsimile or telegram during normal business hours of the recipient and (b) the next Business Day if sent by overnight courier or if sent by electronic transmission, facsimile or telegram
after normal business hours of the recipient. 
 6.5 Waiver of Notice. Notice of any meeting of the Board may be waived
by a member of the Board by a waiver of the notice in writing signed by the Board member entitled to the notice, whether before, at or after the time stated for the meeting. Attendance of a Board member at any meeting, whether in person or by
telephone, as provided above, shall constitute waiver of notice of such meeting, except where a Director attends a meeting for the express purpose of objecting to the transaction of any business on the ground that the meeting is not lawfully called
or convened. 
 6.6 Action Without Formal Meeting. Any action required to be taken at a meeting of the Board, or any
other action that may be taken at a meeting of the Board, may be taken without a meeting if a consent in writing setting forth the action so taken shall be signed by all of the Directors. 

6.7 Agents. The Board may engage on behalf of, and at the expense of, the Company, such persons, firms or corporations as the
Board in its reasonable judgment shall deem advisable for the conduct and operation of the business and affairs of the Company, including, without limitation, managers, leasing, rental and sales agents and brokers, mortgage bankers, securities
brokers and dealers, credit enhancers, lawyers, accountants, architects, engineers, consultants, contractors and purveyors of other services or materials for the Company on such terms and for such compensation or costs as the Board, in its
reasonable judgment, shall determine. 
 6.8 Officers and Employees. 

(a) Authority. The day-to-day operations of the Company shall be managed by the Officers in accordance with the Annual Budget, reporting
to and being subject to the supervision of the Board. The overall management and strategic vision for business and affairs of the Company shall be managed by or under the direction of the Board. 

  
 23 

 (b) Officers. The Company may employ such employees as the Officers of the Company deem
reasonably necessary to effectuate the purposes of the Company as set forth in Section 1.3 of this Agreement. Each Officer of the Company shall have such authority and perform such duties in the management of the Company as an officer of
a Delaware corporation with the same or equivalent title would have. Except as otherwise set forth in this Agreement, Officers may be appointed or removed by a majority of the Board. 

6.9 Fiduciary Duties. Subject to Section 6.10, the Directors and Officers shall have the same fiduciary duties and
obligations to the Company and the Members as a director or officer, as applicable, of a Delaware corporation owes to the corporation and its stockholders. Each Director and Officer shall enjoy each and every protection afforded to the directors and
officers of a Delaware corporation under applicable Delaware law, including, without limitation, those afforded by the business judgment rule and the presumptions afforded thereby and the limitation on personal liability to the maximum extent
permitted by the Delaware General Corporation Law as if the provisions thereof were set forth in this Agreement. To the fullest extent permitted by applicable Delaware law, the Company is authorized to provide indemnification of (and advancement of
expenses to) Directors, Officers and agents of the Company (and any other persons to which applicable Delaware law permits the Company to provide indemnification) through agreements with such agents or other persons, vote of Members or disinterested
Directors or otherwise, in excess of the indemnification and advancement otherwise permitted by applicable Delaware law. Any repeal or modification of the foregoing provisions of this Section 6.9 by the Members shall not adversely affect
any right or protection of a Director or Officer of the Company existing at the time of, or increase the liability of any Director or Officer with respect to any acts or omissions of such Director or Officer occurring prior to, such repeal or
modification. 
 6.10 Disclaimer of Certain Duties. 

(a) Certain Relationships. Because each of the Significant Securityholders, is currently (or may become) a Member of the Company with
the right, and/or is entitled pursuant to the Master Rights Agreement, to designate members of the Board, and in anticipation that the Company and the Significant Securityholders and their respective affiliates may engage in similar activities or
lines of business and/or have an interest in the same areas of opportunities, and in recognition of (i) the benefits to be derived by the Company through its continued contractual and business relations with the Significant Securityholders and
their respective affiliates (including the service of employees, officers or directors of the Significant Securityholders or their respective affiliates as Directors) and (ii) the potential difficulties attendant to any Director fulfilling the
full scope of such Director’s fiduciary duties in any particular situation, the provisions of this Section 6.10 are set forth to regulate, define and guide (A) the conduct of certain activities of the Company as such activities
may involve the Significant Securityholders, their respective affiliates and their respective officers and directors, and (b) the powers, rights, duties and liabilities of the Company and its Officers, Directors and Members in connection
therewith. 

  
 24 

 (b) Certain Business Activities. 

(i) Subject to Section 6.10(c) and any contractual obligations by which any or all of the Significant Securityholders may be bound
from time to time, none of the Significant Securityholders nor any of their affiliates shall have a duty to refrain from engaging, directly or indirectly, in the same or similar business activities or lines of business as the Company or any of the
Company’s affiliates, including those business activities or lines of business deemed to be competing with the Company or any of the Company’s affiliates. To the fullest extent permitted by law none of the Significant Securityholders nor
any of their affiliates, nor any of their respective officers or directors, shall be liable to the Company or its Members, or to any affiliate of the Company or such affiliate’s stockholders or members, for breach of any fiduciary duty, solely
by reason of any such activities of any Significant Securityholder or its affiliates, or of the participation therein by any officer or director of any Significant Securityholder or its affiliates. 

(ii) To the fullest extent permitted by law, but subject to any contractual obligations by which any or all of the Significant Securityholders
may be bound from time to time, none of the Significant Securityholders nor any of its affiliates shall have a duty to refrain from doing business with any client, customer or vendor of the Company or any of the Company’s affiliates, and
without limiting Section 6.10(c), none of the Significant Securityholders nor any of their affiliates nor any of their respective officers, directors or employees shall be deemed to have breached his, her or its fiduciary duties, if any,
to the Company or its Members or to any affiliate of the Company or such affiliate’s stockholders or members solely by reason of engaging in any such activity. 

(c) Corporate Opportunities. 

(i) Subject to any contractual provisions by which the Company or any or all of the Significant Securityholders or their respective affiliates
may be bound from time to time, unless a potential transaction or other matter was expressly offered to a representative of any Significant Securityholder in his or her capacity as a Director or Officer, in the event that any Significant
Securityholder or any of their affiliates or any of their respective officers, directors or employees, acquires knowledge of a potential transaction or other matter which may be an opportunity for any Significant Securityholder (or any of its
respective affiliates), on the one hand, and the Company (or any of its affiliates), on the other hand, none of the Significant Securityholders nor any of their affiliates, officers, directors or employees shall have any duty to communicate or offer
such opportunity to the Company or any of its affiliates, and to the fullest extent permitted by law, none of the Significant Securityholders nor any of their affiliates, officers, directors or employees shall be liable to the Company or its
Members, or any affiliate of the Company or such affiliate’s stockholders or members, for breach of any fiduciary duty or otherwise, solely by reason of the fact that such Significant Securityholder or any of its affiliates, officers, directors
or employees acquires, pursues or obtains such corporate opportunity for itself, directs such opportunity to another person, or otherwise does not communicate information regarding such opportunity to the Company or any of its affiliates, and the
Company (on behalf of itself and its affiliates and their respective stockholders and affiliates) to the fullest extent permitted by law hereby waives and renounces any claim that such business opportunity

  
 25 

 
constituted an opportunity that should have been presented to the Company or any of its affiliates. 

(ii) Subject to any contractual provisions by which the Company or any or all of the Significant Securityholders or their respective
affiliates may be bound from time to time, in the event that an individual who is a Director or Officer and who is also a director, officer or employee of any Significant Securityholder (or any of its respective affiliates) is offered or acquires
knowledge of a potential transaction or matter which may be an opportunity for both the Company and such Significant Securityholder (or any of their affiliates (a “Mutual Corporate Opportunity”), such individual shall, to the
fullest extent permitted by law, be deemed to have fully satisfied and fulfilled his or her fiduciary duty with respect to the Mutual Corporate Opportunity, and the Company (on behalf of itself and its Members and its affiliates and their respective
stockholders or members), to the fullest extent permitted by law, hereby waives and renounces any claim that such Mutual Corporate Opportunity constitutes a corporate opportunity that should be presented to the Company (or any of its affiliates) and
agrees that such Mutual Corporate Opportunity may be pursued and taken advantage of by such Significant Securityholder (or any of its affiliates), as applicable, if such Significant Securityholder (or any of its affiliates) acts in a manner
consistent with the following policy: a Mutual Corporate Opportunity offered to any individual who is a Director or Officer and who is also a director, officer or employee of any Significant Securityholder (or any of their respective affiliates)
shall belong to such Significant Securityholder or its affiliate, as the case may be, unless such Mutual Corporate Opportunity was expressly offered to such individual, or such individual acquired such knowledge, in his or her capacity as a Director
or Officer or any of its affiliates, in which case such opportunity shall not be pursued by such Significant Securityholder or its affiliate, unless either (A) such Mutual Corporate Opportunity is presented to the Board, and the Company or such
affiliate declines to pursue such Mutual Corporate Opportunity, or (B) such Significant Securityholder or its affiliate pursues such Mutual Corporate Opportunity solely as a result of information independently obtained without any disclosure by
such individual who is a Director or Officer. For purposes of this Section 6.10, the term “opportunity” shall include, but not be limited to, investment or business opportunities or activities, potential transactions or matters
which the Company is financially able to undertake, which are, from their nature, in the line of the Company’s business, are of practical advantage to it and are opportunities in which the Company has an interest or a reasonable expectancy, and
in which, by embracing the opportunities, the self-interest of a Significant Securityholder or affiliate of such Significant Securityholder will be brought into conflict with that of the Company. 

SECTION 7 
 BOOKS AND
RECORDS 
 7.1 Books and Records. The Company will keep adequate books and records at its principal place of business,
setting forth a true and accurate account of all transactions and other matters arising out of and in connection with the conduct of the Company’s business, which books and records will be otherwise kept in accordance with the provisions of the
LLC Law. Any Member or its designated representative will have the right, to the extent provided by the LLC Law and at any reasonable time and upon reasonable notice, to have access to and to inspect and copy the contents of such books or
records. 

  
 26 

 7.2 Taxable Year. The accounting period and taxable year of the Company will end on
December 31 of each year. 
 SECTION 8 

ADMISSION OF MEMBERS 
 8.1
Prohibited Transfers. 
 (a) Contravention of Agreement. Any purported Transfer of a Unit that is in contravention of this
Agreement, the Master Rights Agreement, or to the extent applicable, any other agreement entered into by the Company with the transferor, or that would cause the Company to not be treated as a partnership for U.S. federal income tax purposes will be
null and void and of no effect whatsoever; provided, however, that, if the Company is required to recognize a Transfer that is in contravention of this Agreement, or to the extent applicable, any other agreement entered into by the
Company with the transferor, or that would cause the Company to not be treated as a partnership for U.S. federal income tax purposes, (i) the Units so Transferred will be strictly limited to the transferor’s rights to allocations and
Distributions as provided by this Agreement with respect to the Transferred Units, which allocations and Distributions may be applied (without limiting any other legal or equitable rights of the Company) to satisfy any debts, obligations or
liabilities for damages that the transferor or transferee of such Units may have to the Company and (ii) the purported transferee and transferor will become an Assignee with respect to such Units purportedly Transferred in contravention of this
Agreement. 
 (b) Indemnification Obligations of Transferor. In the case of a Transfer or attempted Transfer of a Unit that is in
contravention of this Agreement, the Master Rights Agreement, or to the extent applicable, any other agreement entered into by the Company with the transferor, or that would cause the Company to not be treated as a partnership for U.S. federal
income tax purposes, the parties engaging or attempting to engage in such Transfer will be liable to indemnify and hold harmless the Company and the other Members from all costs, liability and damage that may incur (including, without limitation,
incremental tax liability and attorneys’ fees and expenses) as a result of such Transfer or attempted Transfer and efforts to enforce the indemnity granted hereby. 

8.2 Conditions to Transfers. A Transfer of a Unit that otherwise qualifies under this Agreement, and to the extent applicable,
any other agreement entered into by the Company with the transferor, will not be given effect by the Company unless and until the following conditions are satisfied. 

(a) Documentation. The transferor and transferee shall execute and deliver to the Company such documents and instruments of conveyance
as may, in the reasonable opinion of counsel to the Company be necessary to effect such Transfer and to confirm the agreement of the transferee to be bound by the provisions of this Agreement, including, without limitation, a counterpart signature
page to this Agreement. 

  
 27 

 (b) Required Information. The transferor and transferee will furnish the Company with the
transferee’s taxpayer identification number, sufficient information to determine the transferee’s initial tax basis in the Units transferred, and any other information necessary to permit the Company to file all required federal and state
tax returns and other legally required information statements or returns. Without limiting the generality of the foregoing, the Company will not be required to make any Distribution otherwise provided for in this Agreement with respect to any
Transferred Units until it has received such information. 
 (c) Compliance with Securities’ Laws. Either (i) such Units
will be registered under the Securities Act and any applicable state securities laws, or (ii) the transferor will provide, upon the Company’s reasonable request, an opinion of counsel, which opinion and counsel will be reasonably
satisfactory to the Company, to the effect that such Transfer will be exempt from all applicable registration requirements and that such Transfer will not violate any applicable laws regulating the transfer of securities. 

(d) Substitute Member. The transferor may grant to any transferee of Units permitted hereunder and otherwise in compliance with the
terms of any agreement entered into by the Company with the transferor, the right to become a Substitute Member, with respect to the Units transferred; provided, however, that such transferee shall not become a Substitute Member unless
and until the admission of such transferee is consented to in writing by the Board (excluding the vote of any Director, or affiliate of a Director, that is the transferor), which consent shall not be unreasonably withheld; provided,
further, no Board consent shall be required for any transfer effected in compliance with Section 9 of the Master Rights Agreement. Any transferee of a Unit or Units shall become an Assignee with respect to such Unit or Units unless and
until such transferee is admitted as a Substitute Member pursuant to the prior sentence of this Section 8.2(d). 
 (e)
Expenses. Each Member Transferring Units pursuant to this Section 8.2 shall pay the expenses incurred by the Company in connection with such Transfer, including costs and reasonable attorney fees. 

8.3 Effect of Transfers. 

(a) Allocation of Profits and Losses. If any Unit is Transferred during any accounting period in compliance with the provisions of this
Section 8, Profits, Losses, each item thereof; and all other items attributable to the transferred Unit for such period will be divided and allocated between the transferor and the transferee by taking into account their varying
interests during the period in accordance with Section 706(d) of the Code and the Treasury Regulations thereunder, the Board may, at its option, close the Company books (as though the Company’s taxable year had ended) or make pro rata
allocations of loss, income, and expense deductions to a new Member for that portion of the Company’s taxable year in which a Person became an Member. All Distributions on or before the date of such Transfer will be made to the transferor, and
all Distributions thereafter will be made to the transferee. Solely for purposes of making such allocations and Distributions, the Company will, if otherwise in compliance with this Agreement, recognize such Transfer not later than the end of the
calendar month during which it is given notice of such Transfer, provided that if the Company does not receive a notice stating the date such Unit was Transferred and such other information as the Company may reasonably

  
 28 

 
require within 30 days after the end of the accounting period during which the Transfer occurs, then all of such items will be allocated, and all Distributions will be made, to the Member who,
according to the books and records of the Company, on the last day of the accounting period during which the Transfer occurs, was the owner of the Unit. Neither the Company nor any Member will incur any liability for making allocations and
Distributions in accordance with the provisions of this Section 8.3(a), whether or not the Company has knowledge of any Transfer of ownership of any Unit. 

(b) Existing Terms and Conditions. Any Person who acquires in any manner whatsoever any Units or other interest in the Company shall be
an Assignee until such Person has accepted and adopted in writing the terms and provisions of this Agreement that any predecessor in such Units or other interest in the Company of such Person was subject to or by which such predecessor was bound.

 (c) Termination of Member Status. Any Member who shall Transfer any Units or other interest in the Company shall cease to be a
Member of the Company with respect to such Units or other interest and shall no longer have any rights or privileges of a Member with respect to such Units or other interest. 

8.4 Admission of Members. 

(a) Substitute Members. In connection with the Transfer of Units permitted under the terms of this Agreement, the transferee of such
Units shall become a Substitute Member on the later of (i) the effective date of such Transfer and (ii) the date on which such transferee is approved as a Substitute Member pursuant to Section 8.2(d) of this Agreement, and such
admission shall be shown on the books and records of the Company. 
 (b) Additional Members. A Person may be admitted to the Company
as an Additional Member only (i) as contemplated under Section 3.4 or (ii) as otherwise permitted under this Article 8 and then only upon furnishing to the Company (i) a letter of acceptance, in form
satisfactory to the Company, of all the terms and conditions of this Agreement and (ii) such other documents or instruments as may be necessary or appropriate to effect such Person’s admission as a Member. Such admission shall become
effective on the date on which the Board determines, in its sole discretion, that such conditions have been satisfied and when any such admission is shown on the books and records of the Company. 

8.5 Representations; Legend. Each Member hereby agrees that the following legend may be placed upon any counterpart of this Agreement
or any other document or instrument evidencing ownership of a Unit: 
 THE UNITS REPRESENTED BY THIS DOCUMENT HAVE NOT BEEN REGISTERED UNDER
ANY SECURITIES LAWS AND THE TRANSFERABILITY OF SUCH UNITS IS RESTRICTED PURSUANT TO THE TERMS AND CONDITIONS OF THE COMPANY’S AMENDED AND RESTATED OPERATING AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME. A UNIT MAY NOT BE SOLD, ASSIGNED OR
TRANSFERRED, NOR WILL ANY ASSIGNEE, VENDEE, TRANSFEREE OR 

  
 29 

 
ENDORSEE THEREOF BE RECOGNIZED AS HAVING ACQUIRED ANY SUCH UNIT BY THE ISSUER FOR ANY PURPOSES, UNLESS (1) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT WITH RESPECT TO SUCH UNIT WILL
THEN BE IN EFFECT AND SUCH TRANSFER HAS BEEN QUALIFIED TO THE EXTENT REQUIRED UNDER ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION AND QUALIFICATION WILL BE AVAILABLE. 

THE UNITS REPRESENTED BY THIS DOCUMENT ARE ALSO SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFER AS SET FORTH IN A MASTER INVESTORS’ RIGHTS
AGREEMENT DATED AS OF SEPTEMBER 23, 2013, AMENDED FROM TIME TO TIME A COPY OF WHICH WILL BE FURNISHED BY EVOLENT HEALTH LLC UPON REQUEST. 

SECTION 9 
 LIQUIDATION
OF THE COMPANY 
 9.1 Liquidation Events. Subject to Section 2.3 (including Section 2.3(e)(viii)), the
Company will dissolve, terminate and commence winding up and liquidation upon the first to occur of any of the following (each, a “Liquidation Event”): 

(a) approval by (i) the Board and (ii) the Members as set forth in Section 2.3(a) to dissolve, wind up, and liquidate the
Company; or 
 (b) the happening of any other event that makes it unlawful or impossible to carry on the Business. 

The Members hereby agree that, notwithstanding any provision of the LLC Law, the Company will not dissolve prior to the occurrence of a Liquidation Event.

 9.2 Winding Up. Upon the occurrence of a Liquidation Event, the Company shall continue solely for the purposes of winding up its
affairs in an orderly manner, liquidating its assets and satisfying the claims of its creditors and Members. No Member will take any action that is inconsistent with, or not necessary to or appropriate for, the winding up of the Company’s
business and affairs. The Company’s assets will be liquidated as promptly as is consistent with obtaining the fair market value thereof, and the proceeds therefrom, to the extent legally available and sufficient therefor, will be applied and
Distributed in the following order and priority: 
 (a) Company Creditors. First, to the payment and discharge of all of the
Company’s debts and liabilities to creditors, including Members that are creditors; 
 (b) Member Distribution. Second, the
remaining amount, if any, shall be distributed to the Members in accordance with Section 5.3. 

  
 30 

 Any distribution to a Member pursuant to Sections 9.2(a) and 9.2(b) above
will be net of any amounts owed to the Company by such Member. No Member will receive any additional compensation for any services performed pursuant to this Section 9. 

9.3 Deficit Capital Accounts. if any Member has a deficit balance in its Capital Account (after giving effect to all
contributions, distributions and allocations for all taxable years, including the year during which such liquidation occurs), such Member will have no obligation to make any contribution to the capital of the Company with respect to such deficit,
and such deficit will not be considered a debt owed to the Company or to any other Person for any purpose whatsoever. 
 9.4
Reserves. In the discretion of the Board, a pro rata portion of the Distributions that would otherwise be made to the Members pursuant to this Section 9.2 may be withheld to provide a reserve for Company liabilities (contingent or
otherwise) and to reflect the unrealized portion of any installment obligations owed to the Company, provided that such withheld amounts shall be distributed to the Members as soon as reasonably practicable. 

9.5 Rights of Members. Except as otherwise provided in this Agreement, each Member will look solely to the assets of the Company
for the return of its Capital Contribution and will have no right or power to demand or receive property other than cash from the Company. 

9.6 Prohibition on Withdrawal. No Member is entitled to withdraw from the Company prior to the Company’s dissolution
pursuant to this Section 9. Under no circumstances, other than pursuant to the express terms of this Agreement, will the Company be required to make any Distribution prior to the Company’s dissolution pursuant to this Section
9. 
 SECTION 10 

AMENDMENTS 
 10.1
Authority to Amend. Subject to the provisions of Section 2.3: 
 (a) Substitute Members. This Agreement may be amended
by the Board if such amendment is solely for the purpose of admitting Substitute Members or Additional Members in accordance with the terms of this Agreement. 

(b) Required by Code. This Agreement may be amended by the Board if such amendment is, in the reasonable opinion of counsel for the
Company, necessary or appropriate to satisfy requirements of the Code. Any amendment made pursuant to this Section 10.1(b) may be made effective as of the date of this Agreement to the extent necessary to satisfy such requirements. 

(c) Other. Any other amendment to this Agreement or any decision to convert the Company into a corporation shall require approval by
(i) the Board and (ii) the Members as set forth in Section 2.3(a). 

  
 31 

 10.2 Notice of Amendments. The Members shall be notified as to the substance of any
amendment pursuant to Section 10.1, and upon request shall be furnished a copy thereof. 
 SECTION 11 

MISCELLANEOUS 

11.1 Notices. All notices, requests, demands and other communications under this Agreement must be in writing and will be deemed
duly given, unless otherwise expressly indicated to the contrary in this Agreement, (a) when personally delivered (and if delivered after normal business hours, on the next Business Day), (b) two Business Days after having been deposited
in the United States mail, certified or registered, return receipt requested, postage prepaid, (c) one Business Day after having been dispatched by a nationally recognized overnight courier service, addressed to the parties or their permitted
assigns with an acknowledgment of receipt requested at the following addresses, or (d) upon receipt of confirmation of a facsimile transmission (and if transmitted after normal business hours, on the next Business Day): 

(a) Company. If to the Company, to the Company at the address set forth in Section 1.4 hereof, 

(b) Member. If to a Member, to the address set forth on Exhibit A to this Agreement. Any Person may from time to time
specify a different address by written notice to the Company. 
 11.2 Binding Effect. Except as otherwise provided in this
Agreement, every covenant, term and provision of this Agreement will be binding upon and inure to the benefit of the Members and their respective legal representatives, successors, transferees and permitted assigns. 

11.3 Construction. Every covenant, term and provision of this Agreement will be construed simply according to its fair meaning
and not strictly for or against any Member. 
 11.4 Significant Securityholders. Whenever any provision hereof calls
for a vote of one or more of the Significant Securityholders, the voting by Holdco of Common Units, Series A Preferred Units or Series B Preferred Units at the direction of a Significant Securityholder entitled to direct the voting of such units
pursuant to Section 5.8 of the Master Rights Agreement shall constitute a vote of such Significant Securityholder. 

11.5 Entire Agreement. This Agreement, together with the Certificate, as each of the foregoing may be amended in writing from
time to time, and to the extent referenced herein, the Master Rights Agreement and the Purchase Agreements, contain the entire understanding among the parties hereto and supersede any prior understandings and agreements among them respecting the
subject matter of this Agreement. 
 11.6 Headings. Section and other headings contained in this Agreement are for
reference purposes only and are not intended to describe, interpret, define or limit the scope or extent of this Agreement or any provision hereof. 

  
 32 

 11.7 Severability. Every provision of this Agreement is intended to be severable.
If any term or provision hereof is invalid for any reason whatsoever, such illegality or invalidity will not affect the validity or legality of the remainder of this Agreement. 

11.8 Incorporation by Reference. Every appendix, exhibit, schedule, and other document attached to this Agreement and referred
to herein is hereby incorporated into this Agreement by reference. 
 11.9 Further Action. Each Member agrees to
perform all further acts and execute, acknowledge, and deliver any documents that may be reasonably necessary, appropriate, or desirable to carry out the provisions of this Agreement. 

11.10 Variation of Pronouns. All pronouns and any variations will be deemed to refer to masculine, feminine, or neuter, singular
or plural, as the identity of the Person or Persons may require. 
 11.11 Governing Law. All questions concerning the
construction, validity, and interpretation of this Agreement and the performance of the obligations imposed by this Agreement shall be governed by the internal law, not the law of conflicts, of the State of Delaware. 

11.12 Specific Performance. The parties hereto acknowledge that it is impossible to measure, in money, the damages that shall
accrue to a party or to the personal representative of a decedent from a failure of a party to perform any of the obligations under this Agreement. Therefore, if any party hereto or the personal representative or executor of any party hereto enters
into any action or proceeding to enforce the provisions of this Agreement, any Person (including the Company) against whom the action or proceeding is brought waives the claim or defense that the moving party or representative has or shall have an
adequate remedy at law, and the Person shall not urge in the action or proceeding the claim or defense that an adequate remedy at law exists. 

11.13 Tax Classification. It is the intent of the Members that, prior to any conversion of the Company to a corporate legal entity in
compliance with the provisions of this Agreement and the Management Rights Agreement, the Company shall always be operated in a manner consistent with its treatment as a “partnership” for U.S. federal, state and local income and franchise
tax purposes at all times that it has two (2) or more Members. In accordance therewith, (a) no Member shall file any election with any taxing authority to have the Company treated otherwise, and (b) each Member hereby represents,
covenants, and warrants that it shall not maintain a position inconsistent with such treatment. The Members agree that at all times that it has two (2) or more Members, except as otherwise required by applicable law, they (i) will not
cause or permit the Company to elect (A) to be excluded from the provisions of Subchapter K of the Code, or (B) to be treated as a corporation or an association taxable as a corporation for any tax purposes; (ii) will cause the
Company to make any election reasonably determined by the Tax Matters Member to be necessary or appropriate in order to ensure the treatment of the Company as a partnership for all tax purposes; (iii) will cause the Company to file any required
tax returns in a manner consistent with its treatment as a partnership for tax purposes; and (iv) have not taken, and will not take, any action that would be inconsistent with the treatment of the

  
 33 

 
Company as a partnership for such purposes. Each Member will be treated as a partner for U.S. federal and state income tax purposes with respect to such Member’s Units. 

11.14 Counterpart Execution. This Agreement may be executed in any number of counterparts (including by means of facsimile
signature pages) with the same effect as if all of the Members had signed the same document. All counterparts will be construed together and will constitute one agreement. 

11.15 Venue and Attorney’s Fees. The parties irrevocably submit to the exclusive jurisdiction and venue of the courts
located in the State of Delaware. The parties further agree that in any litigation to enforce the terms of this Agreement, the prevailing party, as determined by the trier of fact, shall have their costs and reasonable attorneys’ fees paid by
the non-prevailing party. 
 11.16 Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE
WAIVED, THE PARTIES HEREBY WAIVE, AND COVENANT THAT THEY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY ACTION ARISING IN WHOLE OR IN PART UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE
TRANSACTIONS CONTEMPLATED HEREUNDER, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE
KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE ITS RIGHT TO TRIAL BY JURY IN ANY PROCEEDING WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREUNDER WILL INSTEAD BE
TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY. 
 *  *  
*  *  *  *  * 

  
 34 

 IN WITNESS WHEREOF, the Parties have entered into this Operating Agreement of Evolent Health LLC
as of the date first above written. 
  

			
	MEMBERS:

  
 35 

 IN WITNESS WHEREOF, the undersigned has duly executed and delivered this Second Amended
and Restated Operating Agreement as of the date first set forth above. 
  

			
	EVOLENT HEALTH HOLDINGS, INC.
		
	By:		/s/ Seth Blackley
			Name:  Seth Blackley
			Title:    President

  

			
	 TPG EAGLE HOLDINGS, LP
  

By: TPG Growth II Advisors, Inc.,
 its general
partner

		
	By:		 
			Name:  
			Title:    

  

			
	THE ADVISORY BOARD COMPANY
		
	By:		 
			Name:  
			Title:    

  
 [Signature Page to
Second Amended and Restated Operating Agreement Evolent Health LLC] 

 IN WITNESS WHEREOF, the undersigned has duly executed and delivered this Second Amended
and Restated Operating Agreement as of the date first set forth above. 
  

			
	EVOLENT HEALTH HOLDINGS, INC.
		
	By:		 
			Name:  Seth Blackley
			Title:    President

  

			
	 TPG EAGLE HOLDINGS, LP
  

By: TPG Growth II Advisors, Inc.,
 its general
partner

		
	By:		/s/ Ronald Cami
			Name:  Ronald Cami
			Title:    Vice President

  

			
	THE ADVISORY BOARD COMPANY
		
	By:		 
			Name:  
			Title:    

  
 [Signature Page to
Second Amended and Restated Operating Agreement Evolent Health LLC] 

 IN WITNESS WHEREOF, the undersigned has duly executed and delivered this Second Amended
and Restated Operating Agreement as of the date first set forth above. 
  

			
	EVOLENT HEALTH HOLDINGS, INC.
		
	By:		 
			Name:  Seth Blackley
			Title:    President

  

			
	 TPG EAGLE HOLDINGS, LP
  

By: TPG Growth II Advisors, Inc.,
 its general
partner

		
	By:		 
			Name:  
			Title:    

  

			
	THE ADVISORY BOARD COMPANY
		
	By:		/s/ Evan Farber
			Name:  Evan Farber
			Title:    General Counsel

  
 [Signature Page to
Second Amended and Restated Operating Agreement Evolent Health LLC] 

 EXHIBIT A 

LIST OF MEMBERS AND CAPITAL CONTRIBUTIONS 
  

																											
	 MEMBER
	  	INITIAL CAPITAL
CONTRIBUTION	 	  	UNITS ISSUED	 	  	Fully
Diluted
Units	 	  	Fully
Diluted
%
	  	  	Series A
Preferred
Members
(Units
Held)	 	  	Series B
Preferred
Members
(Units
Held)	 	  	Series B-1
Preferred
Members
(Units
Held)	 	  	Common
Members
(Units
Held)	 	  	  
	 Evolent Health Holdings, Inc. (“EHH”)
	  	$	120,833,045.61	  	  	 	3,900,000	  	  	 	1,616,844	  	  	 	65,105	  	  	 	1,023,423	  	  	 	6,605,372	  	  	
	 TPG Eagle Holdings, L.P. (“TPG”)
	  	$	55,166,967	  	  	 	0	  	  	 	3,591,844	  	  	 	0	  	  	 	0	  	  	 	3,591,844	  	  	
	 The Advisory Board Company (“ABCO”)
	  	$	20,000,000	  	  	 	0	  	  	 	1,302,172	  	  	 	0	  	  	 	0	  	  	 	1,302,172	  	  	
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  

	 Total
						 	3,900,000	  		 	6,510,860	  		 	65,105	  		 	1,023,423	  		 	11,499,388	  		
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  

 NOTE: For EHH, this Exhibit A reflects the pre-money valuation of the Predecessor Evolent plus cash actually
contributed by Holdco to the Company; for TPG, this Exhibit A reflects cash contributed; and for ABCO, this Exhibit A reflects the face amount of its notes plus accrued but unpaid interest. 

  
 A-1 

 NOTICE ADDRESSES OF MEMBERS 

ABCO: 
 The Advisory Board Company 

2445 M St., NW 
 Washington, D.C. 20037 

Attn: Evan R. Farber, General Counsel 
 Fax: (202) 266-6633

 With a copy to: 
 Morrison & Foerster LLP 

1650 Tysons Boulevard, Suite 400 
 McLean, VA 22102 

Attn: Gregory M. Giammittorio, Esq. 
 Fax: (703) 760-7777

 TPG: 
 301 Commerce Street, Suite 3300 

Fort Worth, TX 76102 
 Attention: General Counsel 

Fax: (817) 871-4088 
 With a copy to: 

Wilson Sonsini Goodrich & Rosati, P.C. 
 One Market
Plaza 
 Spear Tower, Suite 3300 
 San Francisco, CA 94105 

Attn: Todd Cleary 
 EHH: 

Evolent Health LLC 
 800 N. Glebe Road, Suite 500 

Arlington, VA 22203 
 Fax No.: 

with a copy to: 
 Morgan, Lewis & Bockius, LLP 

225 Franklin Street 
 Boston, MA 02110 

Attn: Mark B. Stein, Esq. 
 Fax No: (617) 341-7701 

  
 A-2 

 EXHIBIT B 

DEFINITIONS 
 Unless the
context otherwise specifies or requires, capitalized terms used herein which are not otherwise defined in the text of this Agreement shall have the respective meanings assigned thereto in this Exhibit B, for all purposes of this Agreement
(such definitions to be equally applicable to both the singular and the plural foams of the terms defined). Unless otherwise specified, all references herein to Sections are to Sections of this Agreement. 

“Additional Member” means a Person admitted to the Company as a Member pursuant to Section 8.4(b). 

“Adjusted Capital Account Balance” has the meaning set forth in Exhibit C. 

“Adjusted Series A Liquidation Preference Amount” means an amount per Series A Preferred Unit equal to (i) the
Original Series A Issue Price plus the Unpaid Series A Preferred Return, less (ii) the aggregate amount of all prior Distributions made by the Company with respect to such Series A Preferred Unit pursuant to Section 5.1 and
subclauses (iv), (viii) and (ix) of Section 5.2(d), but in no event less than $0. 
 “Adjusted Series B
Liquidation Preference Amount” means an amount per Series B Preferred Unit equal to (i) the Original Series B Issue Price plus the Unpaid Series B Preferred Return, less (ii) the aggregate amount of all prior Distributions made by
the Company with respect to such Series B Preferred Unit pursuant to Section 5.1 and subclauses (iii) and (ix) of Section 5.2(d), but in no event less than $0. 

“Adjusted Series B-1 Liquidation Preference Amount” means an amount per Series B-1 Preferred Unit equal to (i) the
Original Series B Issue Price plus the Unpaid Series B-1 Preferred Return, less (ii) the aggregate amount of all prior Distributions made by the Company with respect to such Series B-1 Preferred Unit pursuant to Section 5.1 and
subclauses (vi) and (ix) of Section 5.2(d), but in no event less than $0. 
 “Agreement” means this
Operating Agreement, as originally executed and as amended from time to time. Terms such as “hereof,” “hereto,” “hereby,” “hereunder” and “herein” refer to this Agreement as a whole, unless the
context otherwise requires. 
 “Annual Budget” has the meaning given it in Section 2.3(e)(xi). 

“Assignee” means a transferee of a Unit or Units who has not been admitted as a Member pursuant to Section 8.2.
An Assignee shall have no voting rights in the Company with respect to its Unit(s), including, without limitation, any and all rights to participate in the management of the business and affairs of the Company and to vote on any matters as to which
a Member is entitled to vote. The Assignee is only entitled to receive the Distributions and return of capital, and to be allocated the Profits and Losses attributable to the assigned Unit(s) or portion thereof. 

“Board” means the Board of Directors of the Company. 

  
 B-1 

 “Book Value” has the meaning set forth in Section C2(b) of Exhibit
C. 
 “Business” has the meaning given it in Section 1.3. 

“Business Day” means any day other than a Saturday or a Sunday on which trading occurs on the New York Stock Exchange 

“Capital Account” means, with respect to any Member, the Capital Account maintained for such Member in accordance with the
provisions of Section 4.1 and Exhibit C. 
 “Capital Contributions” means, with respect to any Member,
the amount of money and the initial Book Value (as defined in Section C2(b)(i) of Exhibit C) of any assets (other than money) contributed to the Company with respect to the Units held by such Person. 

“Certificate” has the meaning given it in Section 1.1. 

“Code” means the Internal Revenue Code of 1986, as amended, to include the corresponding successor or predecessor provisions
of the U.S. federal internal revenue laws. 
 “Company” means Evolent Health LLC, a Delaware limited liability company.

 “Company’s Minimum Gain” has the meaning set forth in Exhibit C. 

“Common Unit” means the interest of a Common Member in the Company, including, without limitation, rights to (i) vote on
various Company matters as expressly set forth in this Agreement, and (ii) receive Distributions (liquidating or otherwise) and allocations of Profits and Losses. 

“Contingent Consideration” has the meaning set forth in Section 5.3(d). 

“Convertible Securities” means any obligations, evidences of indebtedness or other securities or interests (other than
Options) directly or indirectly convertible or exchangeable into Units or other Equity Interests in the Company. 

“Director” means a member of the Board. 

“Distribution” means each distribution (including distributions made pursuant to Section 5.1) made by the Company
to a Member, whether in cash, property or securities of the Company and whether by liquidating distribution, redemption, repurchase or otherwise; provided, however, that any recapitalization or exchange of Equity Securities of the
Company, and any subdivision (by Unit split or otherwise) or any combination (by reverse Unit split or otherwise) of any outstanding Units shall not be a Distribution. 

“Effective Date” has the meaning given it in the Preamble. 

“Equity Security” means (i) Units or other equity interests in the Company (including other classes or groups thereof
having such relative rights, powers and duties as may 

  
 B-2 

 
from time to time be established by the Board, including rights, powers and/or duties junior, pari passu or senior to existing classes and groups of Units and other equity interests of the
Company), (ii) stock appreciation rights, phantom stock rights or other rights with equity features, (iii) Convertible Securities and (iv) Options. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time. 

“Holdco Board” means the board of directors of Holdco. 

“Initial Consideration” has the meaning set forth in Section 5.3(d). 

“Liquidation Event” has the meaning given it in Section 9.1. 

“LLC Law” has the meaning given it in the Recitals. 

“Mandatory Tax Distribution Amount” has the meaning given it in Section 5.1. 

“Member Loan” has the meaning given it in Section 3.3. 

“Member Nonrecourse Debt Minimum Gain” has the meaning set forth in Exhibit C. 

“Members” means the Common Members, the Series A Preferred Members, the Series B Preferred Members, the Series B-1 Preferred
Members, any Substitute Members and any Additional Members. 
 “Officers” means those individuals appointed by the Board as
officers of the Company in accordance with Section 6.8. 
 “Option” means warrants, options or other rights to
subscribe for or purchase or acquire Units or other Equity Interests in the Company. 
 “Original Series A Issue Price”
means $10.00 per Unit (as adjusted for any Unit splits, reverse Unit splits, Unit combinations and other similar capitalization changes of the Series A Preferred Units). 

“Original Series B Issue Price” means $15.36 per Unit (as adjusted for any Unit splits, reverse Unit splits, Unit
combinations and other similar capitalization changes of the Series B Preferred Units). 
 “Person” means any individual,
partnership, corporation, trust, limited liability company or other entity. 
 “Preferred Units” means the Series A
Preferred Units, the Series B Preferred Units and the Series B-1 Preferred Units. 

  
 B-3 

 “Profits” and “Losses” means for each taxable year or other
period an amount equal to the Company’s taxable income or loss for such year or period, determined in accordance with Code Section 703(a) (for this purpose, all items of income, gain, loss, or ,deduction required to be stated separately
pursuant to Code Section 703(a)(1) shall be included in taxable income or loss), with the following adjustments: 
 (i) any income of
the Company that is exempt from U.S. federal income tax shall be added to such taxable income or loss; 
 (ii) any expenditures of the
Company not deductible in computing its taxable income and not properly chargeable to capital account (as described in and within the meaning of Code Section 705 (a)(2)(B)) or treated as Code Section 705(a)(2)(B) expenditures pursuant to
Treasury Regulations Section 1.704-1(b)(2)(iv)(i) shall be subtracted from such taxable income or loss; 
 (iii) if Company property is
reflected on the Company’s books at other than its adjusted tax basis, then in lieu of depreciation, amortization and other cost recovery deductions taken into account for U.S. federal income tax purposes, there shall be taken into account
depreciation for such year or other period, computed in accordance with the Treasury Regulations issued pursuant to Code Section 704(b); 

(iv) any items that are specially allocated to a Member pursuant to Sections C1(b), C1 (c) and C1(d) (set forth in
Exhibit C to this Agreement) shall not be taken into account in determining Profits and Losses; and 
 (v) for purposes of
determining Profit or Loss upon the sale or other disposition of Company property, then in accordance with the Treasury Regulations under Code Section 704(b), the value of an asset properly reflected on the Company’s books at the time of
sale or other disposition shall be substituted for the property’s adjusted tax basis if at the time of sale or disposition there is a variance in such value and adjusted tax basis. 

Except as may be otherwise provided in this Agreement, all items that are components of Profits and Losses shall be divided among the Members in the same
ratio as they share Profits and Losses. 
 “Purchase Agreements” means the Series B Purchase Agreement and the Series B-1
Purchase Agreements. 
 “Recapitalization” has the meaning given it in Section 2.3(e). 

“Sale of the Company” means either (i) the acquisition of the Company by another entity by means of any transaction or
series of related transactions (including, without limitation, any stock acquisition, reorganization, merger or consolidation but excluding any sale or issuance of Equity Securities of the Company for capital raising purposes) other than a
transaction or series of related transactions in which the holders of the voting Equity Securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or
series of related transactions, as a result of Units held by such holders prior to such transaction or series of related transactions, at least a majority of the total 

  
 B-4 

 
voting power represented by the outstanding voting Equity Securities of the Company or such other surviving or resulting entity (or if the Company or such other surviving or resulting entity is a
wholly-owned subsidiary immediately following such acquisition, its parent); or (ii) the sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company and its subsidiaries taken as a
whole by means of any transaction or series of related transactions, except where such sale, lease, transfer, exclusive license is to a wholly-owned subsidiary of the Company. 

“Securities Act” means the Securities Act of 1933, as amended from time to time. 

“Series A Liquidation Preference Amount” means an amount per Series A Preferred Unit equal to the Original Series A
Issue Price. 
 “Series A Preferred Return” means, with respect to each outstanding Series A Preferred Unit, an amount
equal to 8% of the Original Series A Issue Price per annum calculated from the date of issuance by Predecessor Evolent of the corresponding share of Series A Preferred Stock. 

“Series A Preferred Unit” means the interest of a Series A Preferred Member in the Company, including, without limitation,
rights to (i) vote on various Company matters as expressly set forth in this Agreement and (ii) receive Distributions (liquidating or otherwise) and allocations of Profit and Losses. 

“Series B Liquidation Preference Amount” means an amount per Series B Preferred Unit equal to the Original Series B
Issue Price. 
 “Series B Preferred Return” means, with respect to each outstanding Series B Preferred Unit, an amount
equal to 8% of the Original Series B Issue Price per annum calculated from the date of issuance of such Series B Preferred Unit. 

“Series B Preferred Unit” means the interest of a Series B Preferred Member in the Company, including, without limitation,
rights to (i) vote on various Company matters as expressly set forth in this Agreement and (ii) receive Distributions (liquidating or otherwise) and allocations of Profit and Losses. 

“Series B Purchase Agreement” means that certain Series B Security Purchase Agreement, dated as of September 23, 2013
date hereof, among the Company, certain Members and certain stockholders of Holdco. 
 “Series B-1 Liquidation Preference
Amount” means an amount per Series B-1 Preferred Unit equal to the Original Series B Issue Price. 
 “Series B-1 Preferred
Return” means, with respect to each outstanding Series B-1 Preferred Unit, an amount equal to 8% of the Original Series B Issue Price per annum calculated from the date of issuance of such Series B-1
Preferred Unit. 

  
 B-5 

 “Series B-1 Preferred Unit” means the non-voting interest of a Series B-1
Preferred Member in the Company, including, without limitation, rights to receive Distributions (liquidating or otherwise) and allocations of Profits and Losses. 

“Series B-1 Purchase Agreements” means those certain Series B-1 Purchase Agreements, dated as of the date hereof by and
between Holdco and each of WellStar Health Systems, Inc. and Premier Health Partners. 
 “Significant Securityholder” means
each of The Advisory Board Company, a Delaware corporation, UPMC, a Pennsylvania nonprofit corporation, and TPG Eagle Holdings, LP. 

“Substitute Member” means an assignee who has been admitted to all of the rights of membership pursuant to this Agreement.

 “Surplus Amount” means with respect to distributions pursuant to Section 5.3, that amount remaining for
distribution after the distributions set forth in Sections 5.3(a) and (b) are made. 
 “Tax Matters
Member” has the meaning given to “tax matters partner” in Section 6231 of the Code. 
 “Transfer”
(whether or not such term is capitalized) means any sale, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest or other direct or indirect disposition, or encumbrance, whether with or without consideration,
whether voluntarily or involuntarily and whether by operation of law or otherwise. The terms “Transferee,” “Transferred,” “Transferor” and other forms of the word “Transfer” shall have
correlative meanings. 
 “Treasury Regulations” means the United States Treasury Regulations promulgated under the Code,
and any reference to any section of the Treasury Regulations shall include any final or temporary revision or successor to that section. 

“Unit” means a unit of ownership interest in the Company and shall include the Common Units, Series A Preferred Units
and Series B Preferred Units. 
 “Unpaid Series A Preferred Return” means, as of any date, with respect to each Series
A Preferred Unit, an amount equal to the excess, if any, of (a) the aggregate Series A Preferred Return accrued on such Series A Preferred Unit for all periods prior to such date over (b) the aggregate amount of all prior
Distributions made by the Company to such Series A Preferred Member pursuant to subclause (ii) of Section 5.2(d). 

“Unpaid Series B Preferred Return” means, as of any date, with respect to each Series B Preferred Unit, an amount equal to
the excess, if any, of (a) the aggregate Series B Preferred Return accrued on such Series B Preferred Unit for all periods prior to such date over (b) the aggregate amount of all prior Distributions made by the Company to such Series B
Preferred Member pursuant to subclause (i) of Section 5.2(d). 

  
 B-6 

 “Unpaid Series B-1 Preferred Return” means, as of any date, with respect to each
Series B Preferred Unit, an amount equal to the excess, if any, of (a) the aggregate Series B-1 Preferred Return accrued on such Series B-1 Preferred Unit for all periods prior to such date over (b) the aggregate amount of all prior
Distributions made by the Company to such Series B-1 Preferred Member pursuant to subclause (i) of Section 5.2(d). 

“Voting Preferred Units” means the Series A Preferred Units and the Series B Preferred Units. 

* * * * * * * 

  
 B-7 

 EXHIBIT C 

TAX ALLOCATION AND 

CAPITAL ACCOUNT MAINTENANCE RULES 

Section Cl. Special Rules Regarding Allocation of Profits and Losses. 

 

	 	(a)	Limitations on Loss Allocation. Losses allocated to a Member pursuant to Section 4.2 shall not exceed the maximum amount of losses that can be allocated without causing a Member to have a
deficit in his Adjusted Capital Account Balance at the end of any fiscal year. In the event that any Member would have a deficit in his Adjusted Capital Account Balance as a consequence of an allocation of Losses pursuant to Section 4.2,
the amount of Losses that would be allocated to such Member but for the application of this Section C1(a) shall instead be allocated to the other Members to the extent that such allocations would not cause such other Members to have deficits
in their Adjusted Capital Account Balances and allocated among such other Members in proportion to their positive Adjusted Capital Account Balances. To the extent no Member can be allocated Losses without such allocation causing such Member to have
a deficits in his Adjusted Capital Account Balance, such Losses shall be allocated as if this Section Cl(a) were not in effect. Any allocation of items of income, gain, loss, deduction or credit pursuant to this Section C1(a) shall be
taken into account in computing subsequent allocations pursuant to Section 4.2, and prior to any allocation of items in such Section so that the net amount of any items allocated to each Member pursuant to Section 4.2 and
this Section C1(a) shall, to the maximum extent practicable, be equal to the net amount that would have been allocated to each Member pursuant to the provisions of Section 4.2 and this Section C1(a) if such allocation
under this Section C1(a) had not occurred. 

  

	 	(b)	Special Allocations. Notwithstanding anything to contrary contained in Section 4.2, the following special allocations sections of this Section C1(b) and Section C1(c)
shall in all events apply in determining the allocation of Profits and Losses among the Members and shall be made prior to the allocations required under Section 4.2. 

 

	 	(i)	Nonrecourse Deductions. Nonrecourse Deductions shall be allocated to the Members in the same manner as Loss for such period. 

 

	 	(ii)	 Member Nonrecourse Deductions. Any Member Nonrecourse Deductions for any taxable year shall be allocated to the Member(s) bearing the economic
risk of loss with respect to the Member Nonrecourse Debt to which such Member Nonrecourse 

  
 C-1 

	 	
Deductions are attributable in accordance with Treasury Regulations Section 1.704-2(i)(1). 

  

	 	(iii)	Company Minimum Gain. Notwithstanding any other provisions of this Agreement, if there is a net decrease in Company Minimum Gain during a taxable year, the Members shall be allocated items of income and gain in
accordance with Treasury Regulations Section 1.704-2(f). This Section C1(b)(iii) is intended to comply with the minimum gain charge-back requirement of Treasury Regulations Section 1.704-2(f) and shall be interpreted and
applied in a manner consistent therewith. 

  

	 	(iv)	Member Nonrecourse Debt Minimum Gain. Notwithstanding any provision of the Agreement to the contrary except Section Cl(b)(iii) and subject to the exceptions set forth in Section 1.704-2(i)(4) of the
Treasury Regulations, if there is a net decrease in Member Nonrecourse Debt Minimum Gain during any Company fiscal year, each Member who has a share of the Member Nonrecourse Debt Minimum Gain, determined in accordance with
Section 1.704-2(i)(3) of the Treasury Regulations, shall be specially allocated items of Company income and gain for such year (and, if necessary, subsequent years) in an amount equal to such Member’s share of the net decrease in Member
Nonrecourse Debt Minimum Gain, determined in accordance with Section 1.704-2(i)(5) of the Treasury Regulations. Allocations pursuant to the previous sentence shall be made in proportion to the respective amounts required to be allocated to each
Member pursuant thereto. The items to be so allocated shall be determined in accordance with Section 1.704-2(i)(4) of the Treasury Regulations. This Section C1(b)(iv) is intended to comply with the minimum gain chargeback requirement in
such Section of the Treasury Regulations and shall be interpreted consistently therewith. Solely for purposes of this Section C1(b)(iv), each Member’s Adjusted Capital Account Balance shall be determined prior to any other allocations
pursuant to Section 4 of the Agreement and this Exhibit C with respect to such fiscal year, other than allocations pursuant to Section C1(b)(ii) hereof. 

 

	 	(v)	 Qualified Income Offset. Any Member who unexpectedly receives an adjustment, allocation or distribution described in Treasury Regulations
Section 1.704-1(b)(2)(ii)(d)(4), (5) or (6) that causes a deficit in its Adjusted Capital Account Balance shall be allocated items of income and gain in an amount and a manner sufficient to eliminate, to the extent required by the
Treasury Regulations, such deficit balance as quickly as possible, provided that an allocation pursuant to this Section C1(b)(v) shall be made if and only to the extent that such Member would have a deficit in its Adjusted

  
 C-2 

	 	
Capital Account Balance after all other allocation provided for in Section 4 of the Agreement and this Exhibit C with respect to such fiscal year have been tentatively made as
if this Section C1(b)(v) were not in effect. This Section C1(b)(v) is intended to comply with the alternate test for economic effect set forth in Treasury Regulations Section 1.704-1(b)(2)(ii)(d) and shall be interpreted
and applied in a manner consistent therewith. 

  

	 	(vi)	Code Section 754 Adjustments. To the extent an adjustment to the adjusted basis of any Company asset pursuant to Code Section 734(b) or Code Section 743(b) is required, pursuant to the Treasury
Regulations Sections 1.704-1(b)(2)(iv)(m)(2) or (4) to be taken into account in determining Capital Accounts as the result of a distribution to a Member in complete liquidation of such Member’s
interest in the Company, the amount of such adjustment to the Capital Accounts shall be treated as an item of gain (if the adjustment increases the basis of the asset) or loss (if the adjustment decreases such basis), and such gain or loss shall be
specially allocated to the Members in accordance with their interests in the Company in the event Treasury Regulation Section 1.704-1(b)(2)(iv)(m)(2) applies, or to the Member to whom such distribution
was made in the event that Treasury Regulation Section 1.704-1(b)(2)(iv)(m)(4) applies. 

  

	 	(vii)	Adjustments in Connection with Noncompensatory Option Exercise and Convertible Debt. The Board of Directors is hereby authorized to interpret and implement in its reasonable discretion the allocation provisions
described in the Treasury Regulation 1.721-2. 

  

	 	(viii)	Adjustments in Connection with Compensatory Option Exercise and Forfeiture of Restricted Units. The Board of Directors is hereby authorized to interpret and implement in its reasonable discretion the allocation
provisions of the Proposed Treasury Regulation. 

  

	 	(c)	 Corrective Allocations.The allocations set forth in Section C1(b) (the “Regulatory Allocations”) are intended to
comply with the requirements of Treasury Regulations Sections 1.704-1(b) and 1.704-2. Notwithstanding any other provisions of Section 4.2 of the Agreement or this Section Cl (other than the Regulatory Allocations), the
Regulatory Allocations shall be taken into account as provided for in the following two sentences. Income, gain, loss and deduction shall be reallocated to the extent that such reallocation causes the net aggregate amount of allocations of income,
gain, deduction and loss to each Member to be equal to or more closely approximate the net aggregate amount of such items that would have been allocated to each such Member if the 

  
 C-3 

	 	
Regulatory Allocations had not occurred. This Section C1(c) shall be interpreted and applied in such a manner and to such extent as is reasonably necessary to eliminate, as quickly as
possible, permanent distortions to the economic arrangement of the Members that would otherwise occur as a consequence of the Regulatory Allocations in the absence of this Section C1(c). 

 

	 	(d)	Application of Code Section 704(c). Notwithstanding any other provision of this Agreement, to the extent required by law, taxable income, gain, loss, deduction, and items thereof attributable to
property contributed to the Company by a Member, and Company property that has been revalued pursuant to Section C2(b) shall be shared among the Members so as to take into account any variation between the basis of the property and the
fair market value of the property at the time of contribution or revaluation in accordance with the requirements of Section 704(c) of the Code and the applicable regulations thereunder. In accordance with Section 704(c)(1)(A) of the Code
and Section 1.704-1(b)(2)(iv)(d) of the Treasury Regulations, if a Member contributes property with an initial fair market value that differs from its adjusted basis at the time of contribution, income, gain, loss and deductions with respect to
the property shall, solely for income tax purposes (and not for Capital Account purposes), be allocated among the Members so as to take account of any variation between the adjusted basis of such property to the Company and its fair market value at
the time of contribution pursuant to the traditional method under Section 1.704-3 of the Treasury Regulations. The Members agree that all of the built-in gain attributable to property deemed contributed to the Company from the Predecessor
Evolent is attributable to good will, going concern value and other intangible assets, other than any such assets in which the Company has tax basis as of the date of such contribution. 

 

	 	(e)	Distributions of Nonrecourse Liability Proceeds. If, during a taxable year, the Company makes a distribution to any Member that is allocable to the proceeds of any nonrecourse liability of the Company that
is allocable to an increase in Company Minimum Gain pursuant to Treasury Regulations Section 1.704-2(h), then the Company shall elect, to the extent permitted by Treasury Regulations Section 1.704-2(h)(3), to treat such distribution as a
distribution that is not allocable to an increase in Company Minimum Gain. 

 Section C2. Capital
Accounts. 
  

	 	(a)	 Capital Account Maintenance. The Capital Account of each Member shall, except as expressly stated herein to the contrary,
initially consist of the amount of its initial contribution to the capital of the Company pursuant to Section 4.1 of the Agreement. The Member’s Capital Account shall be increased by (i) the amount of cash or the Book Value of
Contributed Property it subsequently contributes to the Company (net of 

  
 C-4 

	 	
any such Member’s liabilities assumed by the Company or to which the Contributed Property is subject), and (ii) its allocable share of Profits and items thereof, including the Special
Allocations of Sections C1(b) and C1(c), allocated to the Member pursuant to the provisions of this Agreement. Its Capital Account shall be decreased by (i) the amount of any cash distributed to the Member, (ii) the Book
Value of any Company property (after proper adjustment to such Book Value pursuant to Section C2(b)) distributed to the Member (net of the amount of any Company liability assumed by such Member or that is secured by any Company property
distributed to such Member), (iii) the Member’s allocable share of Losses and items thereof, including the Special Allocations of Sections C1(b) and C1(c), allocated to it pursuant to the provisions of this Agreement,
(iv) its share of any expenditures described in Code Section 705(a)(2)(B), and (v) such other items as are required by the Treasury Regulations. 

  

	 	(b)	Book Value and Revaluation of Company Property. “Book Value” means, with respect to any asset of the Company, such asset’s adjusted basis for U.S. federal income tax purposes, except as
follows: 

  

	 	(i)	The initial Book Value of Contributed Property shall be its Agreed Value. 

  

	 	(ii)	The Book Value of all Company assets shall be adjusted to equal their respective gross fair market values, as determined by the Board in accordance with Code Section 7701(g), as of the following times:

  

	 	(A)	the acquisition of an additional interest in the Company by any new or existing Member in exchange for more than a de minimis Capital Contribution (as the term “de minimis” is used in Treasury Regulation Section 1.704-1(b)(2)(iv)(f)) or in exchange for services (if the Board reasonably determines that such adjustment is necessary or appropriate to reflect the economic interests of the Members);

  

	 	(B)	the distribution by the Company to a retiring or continuing Member as consideration for Units in the Company of more than a de minimis amount of money or other Company property (if the Board reasonably determines that
such adjustment is necessary or appropriate to reflect the economic interests of the Members); and 

  

	 	(C)	the Liquidation of the Company within the meaning of Treasury Regulation Section 1.704-1(b)(2)(ii)(g). 

  
 C-5 

	 	(iii)	If the Book Value of an asset has been determined or adjusted pursuant to Section C2(b)(ii)(A) or (B) of this Exhibit C, such Book Value shall thereafter be adjusted for the Depreciation taken into
account with respect to such asset for purposes of computing Profits and Losses. 

  

	 	(iv)	If the Book Value is adjusted as required or permitted under this Agreement, the Member’ respective Capital Accounts shall also be adjusted to reflect the adjustments to the Book Value of such assets in accordance
with Treasury Regulations Section 1.704-1(b)(2)(iv)(g). 

  

	 	(v)	Where the Book Value of Company property may, but is not required to, be revalued, the decision of whether to revalue the Company property and the Members’ Capital Accounts, and the amount of any such adjustments
shall be determined by the Board using such reasonable methods of valuation as the Board may adopt. 

  

	 	(c)	Effective Termination Under Code Section 708(b)(1)(B). A transferee of all or part of a Member’s Membership Interest will succeed to the Capital Account (or portion thereof) relating to the
interest transferred; provided, however, that if the transfer causes a termination of the Company under §708(b)(1)(B) of the Code, solely for income tax purposes, the Company properties shall be deemed to have been contributed to
a new limited liability company in exchange for all of the interests in such new limited liability company, which interests will then be deemed to be distributed in liquidation of the Company to the Members (including the transferee of an interest).
The Capital Accounts of such new limited liability company shall be maintained in accordance with the principles set forth herein, the Agreement will apply to such new limited liability company, and all references herein to the Company will become
references to the new limited liability company. 

  

	 	(d)	Revaluation Allocations. For purposes of computing the amount of any item of income, gain, deduction or loss to be reflected in the Members’ Capital Accounts upon a revaluation of Company property,
the determination, recognition and character of any such item shall be the same as its determination, recognition and character for U.S. federal income tax purposes, taking into account any adjustments required pursuant to Section 704(b) of the
Code and the applicable Treasury Regulations thereunder. 

 Section C3. Allocation of Partnership
Liabilities. 
 The Company will follow Treasury Regulation Section 1.752-3 in allocating nonrecourse liabilities to
Members. Additionally, the Board may elect to allocate excess nonrecourse 

  
 C-6 

 
liabilities (those not allocated under Treasury Regulation Section 1.752-3(a)(1) and (2)) to any Member up to the amount of built-in gain that is allocable to the Member on
Section 704(c) property (as defined under Treasury Regulation Section 1.704-3(a)(3)(ii)) where such property is subject to the nonrecourse liability to the extent that such built-in gain exceeds the gain described in Treasury Regulation
Section 1.752-3(a)(2) with respect to such property. 
 With respect to the allocation of a single nonrecourse liability among multiple
properties, the Tax Matters Member may allocate the liability among the multiple properties under any reasonable method in accordance with Treasury Regulation Section 1.752-3(b)(1). 

Section C4. Definitions. 

The capitalized words and phrases used in this Exhibit C, if not otherwise defined in the Agreement, shall have the following meanings
(such meanings shall be equally applicable to both the singular and plural forms of such words and phrases): 
  

	 	(a)	Adjusted Capital Account Balance: “Adjusted Capital Account Balance” shall mean the balance in the Capital Account of a Member as of the end of the relevant fiscal year of the Company, after
giving effect to the following: (i) credit to such Capital Account of any amounts the Member is deemed obligated to restore pursuant to the penultimate sentences of Sections 1.704-2(g)(1) and 1.704-2(i)(5) of the Treasury Regulations, and
(ii) debit to such Capital Account of the items described in Sections 1.704-1(b)(2)(ii)(d)(4),(5) and (6) of the Treasury Regulations. 

  

	 	(b)	Agreed Value: “Agreed Value” shall mean the fair market value of Contributed Property as agreed to by the contributing Member, the other Members and the Company, using such reasonable method of
valuation as they may adopt. However, if the value of any Contributed Property is redetermined by any federal or state agency or by any federal or state court having jurisdiction over the Company or the Members, the value set forth in this Agreement
shall be modified and amended to reflect the value ultimately determined by said agency or court. 

  

	 	(c)	Capital Contribution: “Capital Contribution” shall mean the amount in cash or the agreed value of Contributed Property or services contributed or to be contributed by each Member to the capital
of the Company for such Member’s interest in the Company. 

  

	 	(d)	Company Minimum Gain: “Company Minimum Gain” shall have the meaning given to the term “Partnership Minimum Gain” as set forth in Sections 1.704-2(b)(2) and 1.704-2(d) of the Treasury
Regulations, and any Member’s share of Company Minimum Gain shall be determined in accordance with Treasury Regulations Section 1.704-2(g)(1). 

  

	 	(e)	Contributed Property: “Contributed Property” shall mean each Member’s interest in any property or other consideration (excluding services and cash) contributed to the Company by such Member.

  
 C-7 

	 	(f)	Depreciation: “Depreciation” shall mean, for each taxable year or other period, an amount equal to the depreciation, amortization or other cost recovery deduction, as computed for U.S. federal
income tax purposes, allowable with respect to an asset of the Company for such year or other period, except that if the Book Value of a Company asset differs from its adjusted basis for U.S. federal income tax purposes at the beginning of such year
or other period, Depreciation shall be an amount that bears the same ratio at such beginning Book Value as the U.S. federal income tax depreciation, amortization or other cost recovery deduction for such year or other period bears to such beginning
adjusted tax basis. 

  

	 	(g)	Member Nonrecourse Debt: “Member Nonrecourse Debt” shall have the meaning given to the term “Partner Nonrecourse Debt” as set forth in Section 1.704-2(b)(4) of the Treasury
Regulations. 

  

	 	(h)	Member Nonrecourse Debt Minimum Gain: “Member Nonrecourse Debt Minimum Gain” shall mean an amount, with respect to each Member Nonrecourse Debt, determined in the same manner as “Partner
Nonrecourse Debt Minimum Gain” would be determined in accordance with Section 1.704-2(i) of the Treasury Regulations. 

  

	 	(i)	Member Nonrecourse Deductions: “Member Nonrecourse Deductions” shall have the meaning given to the term “Partner Nonrecourse Deductions” as set forth in Section 1.704-2(i)(2) of
the Treasury Regulations. For any Company taxable year, the amount of Member Nonrecourse Deductions with respect to a Member Nonrecourse Debt equal the net increase during the year, if any, in the amount of Member Nonrecourse Debt Minimum Gain
reduced (but not below zero) by proceeds of the liability that are both attributable to the liability and allocable to an increase in the Member Nonrecourse Debt Minimum Gain. 

 

	 	(j)	Nonrecourse Deductions: “Nonrecourse Deductions” shall have the meaning set forth in Section 1.704-2(b)(1) of the Treasury Regulations. The amount of Nonrecourse Deductions for a Company
fiscal year equals the excess, if any, of the net increase, if any, in the amount of Company Minimum Gain during that fiscal year over the aggregate amount of any distributions during that fiscal year of proceeds of a Nonrecourse Liability that are
allocable to an increase in Company Minimum Gain, determined according to the provisions of Section 1.704-2(c) of the Treasury Regulations. 

  

	 	(k)	Nonrecourse Liability: “Nonrecourse Liability” shall have the meaning set forth in Section 1.704-2(b)(3) of the Treasury Regulations 

  
 C-8 

  
 D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]